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ABSTRACT 
 
          “ A  study to assess the effectiveness of   povidone –iodine (2%) vs normal saline 
(0.9%) mouth rinsing on oral mucositis among patients receiving external radiation therapy 
for head and neck malignancy  from Devaki Cancer and Research Centre at Madurai”. The 
research design adopted for the study was quasi experimental pretest, post test two group 
design. The simple random sampling technique was used by lottery method to select the 30 
samples for experimental group- I and 30 samples for experimental group- II, who fulfilled 
the inclusion and exclusion criteria. The experimental group- I was receiving 10 ml of 
povidone –iodine (2%) mouth rinsing for two times for continuous 14 days. The 
experimental group- II was treated with 20 ml of normal saline (0.9%) mouth rinsing two 
times a day for continuous 14 days after receiving routine mouth care . The oral mucositis 
status was assessed by using oral mucositis assessment scale (OMAS) for experimental 
group- I and experimental group- II on 7
th
 and 14
th
 day. Collected data were analyzed in 
terms of both descriptive and inferential statistics. A probability of  < 0.05 was considered 
to be significant. Findings of the study was evidenced that the mean post test  oral 
mucositis score of experimental group- I (4.03) after povidone-iodine mouth rinse 
significantly lower than the experimental group II (4.8) who have received normal saline 
mouth rinse. The mean post test erythema score of experimental group- I (1.33) was 
significantly higher than the experimental group-II (1.3). There was a significant 
association between the pre test oral mucositis score of experimental group- II with age     
(χ2 =86.8, P> 0.05%). There was no association between the pre test oral mucositis score of 
experimental group I with demographic variables such as age, sex, education, occupation, 
marital status, history of smoking, betel nut chewing and pan or kutka chewing. Both 
mouth rinses which were used in this study were found to be effective. Among this 
povidone- iodine (2%) is found to be superior in reducing oral mucositis in subjects who 
has received radiation therapy when compared to normal saline mouth rinse. 
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CHAPTER   -1 
INTRODUCTION 
 
   BACKGROUND  OF THE STUDY: 
“Time  is shortening but every day that I challenge this cancer and  
survive is a victory for me” 
-Ingird Bergman 
 
Cancer is a generic term for a large group of disease that can affect any part   
of the body.   Other terms used are malignant tumors and neoplasm‟s.  One    defining     
feature   of  cancer    is  the  rapid  creation of  abnormal cells   that  grow    beyond    
their    usual   boundaries  and   which  can   then  invade   adjoining   parts  of   the  
body  and spread   to  either    organs   of  the    body    and   spread to  the  other 
organs this process  is    referred  to  as  metastasis. (Who.int/cancer)    
              Tatiana  macfarlane and Sudhir nair (2012)  defined   head   and  neck   
cancer  that  arises  in  the  head  and  neck  region (in  the  nasal  cavity   sinuses,  
lips,  mouth,  salivary    glands,  throat  or  larynx , primary   tumor) most  head  and    
neck  cancers  are  squamous  cell  carcinomas.  world wide  the  head  and   neck  
cancer.  It  is  the  most  common  cancer  of  males  in   India  and  the  fifth  most  
common  in  females  .  In  India  the  age  adjusted  rates  among  females  is    the  
highest . 
                Poonam  joshi and  Pankaj  chaturvedi  (2014)  stated  that  head   and  neck  
cancer   are  the  most  common   cancers   in  developing   countries,   especially  in  
southeast  Asia.  Head  and  neck    cancers  are  more  common  in  males  compared  
to   females  this  is  mainly    attributed  to  tobacco    nut  chewing,  alcohol  etc.oral  
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cancers  are  most    common    amongst   all  head  and  neck  squamous   cell  
carcinoma. 
                Mountzios (2015) described that head and neck cancer (HNC) represents 
the sixth most common malignancy and accounts for approximately 6% of new 
cancer cases annually worldwide. As life expectancy constantly increases, the onset 
of HNC in patients older than 65 years of age at diagnosis is not rare and up to one 
fourth of cases occurs in patients older that 70 years at age. The frailty of elderly 
patients with HNC is attributed to the high incidence of smoking and alcohol abuse in 
this malignancy and the presence of substantial cardiovascular, respiratory or 
metabolic co morbidities.  
              Staffurth et al.,(2010)explained that treatment of H&N cancer can consist of 
surgery, radiotherapy or chemotherapy and various combinations of the three in 
different temporal sequences or concurrently. Over the last 20 years, a range of 
innovative radiotherapies have been appraised. These include altered fractionation 
schedules; use of new radio therapeutic technologies, use of metallic compensators, 
and combinations with different chemotherapy and drug combinations. 
Christiane  Miaskowski and Aishan shih (2013) Stated that Radiation therapy 
remains the primary methods of treatment for patients with head and neck cancer. The 
tissue destruction and functional alterations in the oral cavity lead to the development 
of oral mucositis. 
             David, Rosenthal and Andrea Trotti (2009) revealed that  Radiation-induced 
mucositis  is a common toxicity for head and neck cancer  patients. The frequency has 
increased because of the use of more intensive altered radiation fractionation and 
concurrent chemotherapy regimens. The extent of the injury is directly related to the 
mucosal volume irradiated, anatomic sub site exposed, treatment intensity, and 
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individual patient predisposition. The consequences of mucositis include pain, 
dysphagia including feeding tube dependency, dehydration, micronutrient 
deficiencies, weight loss, and potentially life-threatening aspiration. 
              Oien and Truelove (2012) stated that Oral mucositis is a complication 
affecting many patients receiving chemotherapy, head and neck radiation and those 
undergoing bone marrow transplant therapies. Caterina da Mota (2012) defined Oral 
mucositis is an inflammation of oral mucosa resulting from cancer therapy typically 
manifesting an atrophy, swelling, erythema and ulceration. 
            Sonis et al.,( 2011) explained  that  a  biological model for chemotherapy- and 
radiotherapy-induced oral Mucositis.  The model includes events that have been 
described in five overlapping stages: initiation, up regulation, message generation, 
ulceration, and healing. All these events lead to pain and, in neutropenic patients, 
bacteria may invade the systemic circulation causing bacteremia and sepsis. 
Following cessation of the injurious therapy, healing occurs and the epithelium 
appears normal again. 
         Samin  radiat (2009) described that  radiation  induced  mucositis  associated  
symptoms  arising   during  radiation therapy  for  head  and  neck cancer are mouth  
and  throat  sores  “ difficulty in  swallowing ,pain, altered  taste,  excessive  
secretions  which  may  lead  to  gagging ,  nausea  and  vomiting, loss of  appetite , 
fatigue, and weight  loss. 
            Rajesh and lalla (2008) revealed that  oral mucositis(OM) can be very painful 
and can significantly affect nutrition intake, mouth care, and quality of life 
.Management  of oral mucositis is to be focused on  nutrition support, pain control, 
oral decontamination, palliation of dry mouth , management of oral bleeding and 
therapeutic interventions for oral mucositis. 
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             Jurema  fraire (2012)  described  that  the  treatment  for  oral  mucositis  
include  laser  therapy,  cryotherapy , growth  factors,  analgesics,  mouth  washes,  
administration  of  antimicrobial  agents,  vitamins  and  anti inflammatory  agents. 
             Elting , et al.,(2007) stated that a reproducible OM scale is a vital prerequisite 
for both research into preventing and managing OM and routine clinical patient care. 
A wide variety of scales have been developed. These focus on symptomatic and 
functional outcomes such as pain or ability to eat, clinical manifestations based on 
direct inspection of the oral mucosal surfaces, or a combination of both. 
          Anne Margrete Gussgard, (2012) explained Oral mucositis (OM) signs were 
evaluated clinically using the National Cancer Institute (NCI) common toxicity 
criteria (NCI-CTC)  ,oral mucositis assessment scale(OMAS)criteria and Total VAS-
OMAS score. OM symptoms were recorded on PROMS-VAS questionnaires. 
           Henry and Hoffman (2003) stated that commonly used scoring tools are the 
World Health Organization (WHO) and the National Cancer Institute (NCI) common 
toxicity criteria (NCI-CTC). The WHO scale is the most widely used and includes 
criteria which are objective (presence of erythema and ulceration), subjective (oral 
pain), and functional (patient‟s ability to eat) to determine an overall score. And the 
Oral Mucositis Assess -ment Scale (OMAS) has examined utility in a multicenter 
study, assessing inter examiner and intra examiner reliability, and it represents the 
only validated mucositis scale that separates mucosal damage from symptoms and 
oral function. 
            Roopashri and Jayanthi (2011) explained that Povidone- iodine has a wide 
antiseptic effects including antiviral, antibacterial and antifungal efficacy and its good 
tolerability have resulted in frequent use as preventive and therapeutic drug in 
radiotherapy and chemotherapy induced mucositis.   
5 
            Hashemi, Bahrololoumi and Khaksar (2015) explored that Normal saline 
(sodium chloride 0.9% solution) is a harmless bland isotonic oral rinse which has 
been shown to be beneficial in maintaining appropriate oral hygiene due to its safety, 
lowest toxicity and physiologic properties. 
            Ohrn and Wahli (2000) explained that Good oral hygiene maintenance before 
and during cancer therapy can minimize the complications associated with the 
treatment and provide greater comfort to patients. 
           Nurses are the frontline professional of the health care. Nurses today are 
actively  involved  generating and publishing best cost effectives evidences in order 
to improve care and expands nursing knowledge . This has motivated the researcher 
to identify the best cost effective, non irritating  mouth rinse to alleviate the mucositis 
associated morbidity  and enhance the  uninterrupted treatment adherence.  
         Carter, Harris and Kavi,(2009) described that  radiotherapy for head and neck 
cancers and chemotherapy for cancers in general are known to cause various 
deleterious effects on the oral structures leading to development of mucositis, candida 
infection, xerostomia, loss of taste sensation, radiation carries, and osteochemo or 
radionecrosis. These Oral care is essential before and during cancer treatment to 
prevent oral complications. Nurses have the crucial role in providing bedside 
supportive care to patients suffering from cancer.  
 
 
 
 
 
 
6 
NEEDS FOR THE STUDY: 
                    “ Brush your teeth every day, to keep dentist away” 
                                                                                               -George Taylor 
 
           According to the union  for  international  cancer  control  (2014)  world  wide  
there  are  approximately  560,000  new  cases   of  head  and  neck  cancer  diagnosed  
and  3, 00,000  deaths  each  year. 
            Karthikeyan guru and udaya kumar  manor (2012) stated that Cancer  is  a    
leading  health    problem  in  India,  with  approximately  1 million  cases occurring  
each  year . Over 200,000 cases of head and neck cancer                                          
(HNC) occur each year in India versus 30,000 for the USA. Cancer accounts for 8% 
of the deaths in India. Incidence of HNC primaries has shown to increase with age. 
Although the functional and cosmetic deficits are very apparent in HNCs, this group 
of cancers accounts for only 5% of all malignancies.  
         Shrotriya,Agarwal and Sclafani (2015) described that head and neck squamous 
cell carcinoma (HNSCC) accounts for around 6% of all cancers in the USA. Few of 
the greatest obstacles in HNSCC include development of secondary primary tumor, 
resistance and toxicity associated with the conventional treatments, together 
decreasing the overall 5-year survival rate in HNSCC patients to ≤50%. Radiation 
and chemotherapy are the conventional treatment options available for HNSCC 
patients at both early and late stage of this type of  malignancy. 
          Jemal , Siegel and  Ward (2010) explained that approximately 36,540 new 
cases of oral cavity and pharyngeal cancer are diagnosed in the USA, more than 7,880 
people  die of this disease. The majority of these cancers are squamous cell 
carcinomas. Most cases are diagnosed at an advanced stage: 62 percent have regional 
or distant spread at the time of diagnosis. The five-year survival for all stages 
combined is 61 percent. Localized tumors (Stage I and II) can usually be treated 
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surgically, but advanced cancers (Stage III and IV) require radiation with or without 
chemotherapy as adjunctive or definitive treatment. Therefore, most patients with oral 
cavity and pharyngeal cancer receive head and neck radiation therapy (RT) as part of 
their treatment. 
             Napier, Scheerer and Misra ( 2014) stated that  the National Cancer Institute 
estimated that there were about 18,000 new cases and more than 15,000 deaths from 
oesophageal cancer in 2013 (the American Cancer Society estimated that during 
2014, about 18,170 new oesophageal cancer cases would be diagnosed, resulting in 
15,450 deaths).  
         Sol Silverman (2006) defined oral mucositis is a common complication in 
cancer patients receiving chemotherapy or radiation therapy. Nearly all patients 
undergoing myeloablative therapy for stem-cell or bone marrow transplantation 
experience oral mucositis. Those receiving radiation therapy for head and neck cancer 
are at especially high risk. However, this toxicity also occurs with standard-dose 
chemotherapy and can be seen in association with treatment of many other tumor 
types. Oral mucositis significantly complicates cancer treatment by contributing to 
pain, dysphagia, weight loss, depression, higher risk of infection, decreased quality of 
life, and increased healthcare costs.  
            Brandwein-Gensler and  Smith (2010) explored that the oral complications of 
head and neck radiation therapy result  from radiation injury to the salivary glands, 
oral mucosa and taste buds, oral musculature, alveolar bone, and skin. They are 
clinically manifested by xerostomia, oral mucositis, dental caries, accelerated 
periodontal disease, taste loss, oral infection, trismus, and radiation dermatitis. 
            Verdi (2005) conducted a descriptive study  to find out the incidence of oral 
mucositis in cancer treatment. Patients receiving radiation therapy and chemotherapy 
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were included in the study. Patients oral cavity was assessed weekly and identified 
that patients receiving chemotherapy oral mucositis usually develops from 10 to 12 
days of administration and in radiation therapy mucositis occurred after 7 to 10 days 
of administration, the incidence and severity was high in patients receiving both. 
           Vera-Llonch and Oster (2007)explained that  patients treated with radiation 
therapy for head and neck cancer typically receive an approximately 200 cGy daily 
dose of radiation, five days per week, for 5–7 continuous weeks. Almost all such 
patients will develop some degree of oral mucositis. In recent studies, severe oral 
mucositis occurred in 29–66% of all patients receiving radiation therapy for head and 
neck cancer . The incidence of oral mucositis was especially high in 1) patients with 
primary tumors in the oral cavity, oropharynx or nasopharynx, 2) those who also 
received concomitant chemotherapy, 3) those who received a total dose over 5000 
cGy, and 4) those who were treated with altered fractionation radiation schedules 
(e.g. more than one radiation treatment per day). 
           Pankaj chaturvedi and Sourav dutta (2014) defined  Oral  mucositis  refers  to  
erythematous  and    ulcerative  lesions  of  the  oral  mucosa  observed  in  patients    
with  cancer  being treated  with chemotherapy  and  with  radiation    therapy  to  the  
type   of  radiation  and  to  the  total  dosage ,  fractionation  and  duration  of  
treatment  .  oral  mucositis  can  occur  with  cumulative  RT  doses  as  or   as  occur  
1000-2000  centigrey  with  therapy  administered  of  a  rate  of  200  cg  %  per  day.  
  American  cancer  society  (2001) explained that The  incidence  of  
oral  pain  is  chemotherapy  is  40-70 %   almost  100%  in  radiotherapy  and  60-85  
with    radiation   induced  mucositis. 
Talita  ribeiro and Tanario  franca  (2012)described that  Radiation  induced   
mucositis  typically  begins  at  cumulative  doses  of  about  15 Gy (after  about  10  
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days)  and  typically  reaches  full  severity  at  30  G  and    lasts  for  weeks  or  even  
months.  Patients  with  oral  mucositis  are  significantly  more  likely  to   experience  
severe  pain  and  weight  loss   severity  of  oral   mucositis  has  been  correlated  
with  compromised  swallowing   function  in  patient   resulting  in the  requirement  
for  feeding  via  a    gastrotomy  tube. 
             Joel Epstein and Stephen sonis (2004) stated that  the majority  of  patients  
receiving   radiation     therapy   for   head    and     neck    cancer    are    unable    to  
continue     eating  by  mouth   due  to  mucositis  pain  which make them to receive  
nutrition  through  a  gastrostomy  tube or  intravenous  line.  In  one  study,   
approximately  16%  of    patients  receiving  radiation    therapy  for  head  and  neck  
cancer  were  hospitalized   due  to    severe oral mucositis  .  Further 1%  of  the  
patients  receiving  radiation  therapy  for  head  and  neck   cancer  had  unplanned  
breaks  in  radiation   theraphy   due  to  severe oral  mucositis .  Oral  mucositis  can  
be  very  painful  and  can  significantly  effect  nutritional  intake ,  mouth  care  and  
quality  of  life. 
            Keefe et al.,(2013)  described that Oral mucositis is a frequent, clinically 
important, and often dose-limiting, complication of cancer therapy. It results from 
injury to epithelial cells that line the oral cavity and can affect the entire alimentary 
tract. Damage causes changes ranging from mild atrophy to severe ulceration. 
        Dolivet  and  Toussaint (2001) reviled that  Current  management  of  oral  
mucositis  of  the  use   of  topical  anesthesics  and  anti-inflammatory   drugs(eg  
lidocaine ,  diphenhydramine)  and  agents  such  as  colloidal  silver  solutions,  salt  
and  soda  rinses  or  hydrogen.  These  agents  have  any  significant  effect   on  
mucositis  although    they  may  improve  patient  comfort.An  ideal  oral  rinse  for  
patients  with  head  and  neck  malignancies should reduce  the  oral  microflora,  
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promote,  re-epithelization  of  soft  tissue  lesions,  normalize  the  ph  of  oral  fluids  
have  an  acceptable  taste  and  be  nontoxic. 
Orecchia (2008) done  a study to assess the effectiveness of povidone iodine in 
reducing radiation induced oral mucositis. In this study 132 patients were randomly 
assigned to use normal saline (n=65) or povidone iodine diluted 1:100(n=67) mouth 
rinse for oral mucositis prophylaxis and treatment after high dose of radiation 
therapy. The  mechanical effect of  povidone iodine (1:100) was reducing the 
incidence of radiation therapy oral mucositis than the control group. 
 Farrington (2010) did a study to assess the  effectiveness of povidone iodine 
mouthwash on radiation or chemotherapy induced oral mucositis: A randomized 
double blind clinical study was conducted to determine and compare the efficiency of 
povidone iodine mouthwash, chamomile and normal saline mouthwash for the 
treatment of oral mucositis. The study was conducted on 83 patients who received 
chemotherapy and have oral mucositis. ANOVA and „t‟test was used for data 
analysis. Significant difference was found between povidone iodine mouthwash, 
chamomile and normal saline group in the score of severity of stomatitis (p=0.017), 
stomatitis pain (p=0.027). The findings indicated that povidone iodine mouthwash 
and chamomile have equal efficiency in chemotherapy induced oral mucositis as 
compared to the normal saline group. 
Madan Kumar and Sequeira (2008)  done a study to assess the effect of three 
alcohol-free mouthwashes on radiation-induced oral mucositis in patients with head 
and neck malignancies  scheduled to undergo curative radiotherapy, were randomly 
assigned to receive one of the three alcohol-free test mouthwashes (0.12% 
chlorhexidine, 1% povidone-iodine, or salt/soda) or a control.This study demonstrated 
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that use of alcohol-free povidone-iodine mouthwash can reduce the severity and delay 
the onset of oral mucositis due to antineoplastic radiotherapy. 
          The National Comprehensive Cancer Network (2008) stated that the 
educational program is designed to meet the needs of advanced practice nurses, 
medical oncologists, radiation oncologists, and hematologists who treat and manage 
patients with cancer who experience treatment-induced mucositis. 
Parker, Epstein and Gupta (2007)  stated that the oral health care team serves 
a vital role in the prevention and management of short- and long-term oral 
complications of cancer treatment. Hospital-based dentists specially trained in oral 
oncology treat some of these patients. It is essential that all health professionals 
caring for the cancer patient be knowledgeable about the diagnosis, prevention and 
management of oral complications of therapy and their sequelae, in order to work 
together as a team to minimize the impact of these toxicities on the patient‟s life. 
            Barbara, Given and Sandra(2011) described that  healthcare providers need to 
monitor and facilitate adherence by identifying barriers and implementing strategies 
to assure adherence, and therefore, improve clinical outcomes. 
June Eilers and  Rita Million(2011) stated that Nurses play a key role in the 
identification and use of evidence to guide the care of patients at risk for cytotoxic 
therapy-related oral mucositis. 
Radhika and Ravikiran Ongole(2015)explored that  the Oncology nurses need 
to have frequent continuing nursing education specific to cancer patient care, and this 
requires involvement from a multidisciplinary team involving dentists, radiation 
oncologists, and medical oncologists on how to perform oral cavity examination and 
recognize the signs and symptoms of oral changes associated with cancer therapy. 
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           Hijji (2013) revealed that the development and implementation of more 
specific oral care protocol can lead to promotion of oral health by health care 
professionals, ensuring that oral care is performed regularly across the hospital, 
minimizing the severity and duration of radiation-induced, and standard dose 
chemotherapy-induced oral mucositis and its complications, ensuring that patients‟ 
treatment is not compromised because of oral problems as well as there is no 
extension of length of hospital stay. 
         Robin(2010)explained that  Nurses need to keep abreast of the latest 
knowledge in oral care of cancer patients, assessment of oral cavity, oral care agents, 
and evidence-based interventions in care of cancer patients undergoing chemotherapy 
and radiation therapy. 
Jayaram  shetty etal., (2008)  done a systemic  reviews and  literatures  related 
to   the   evidence  of  mouth  rinses in  reducing  the  severity  of  oral  mucositis.    
Many evidences showed  that the  preferences  and  adherence  to  mouth  rinses  to 
prevent  mucositis  associated  pain,  difficult  swallowing  impaired  nutrition  and  
thereby  it enhanced  the  refreshes  of  oral  cavity. Nurses are the frontline 
professional of the health care. Nurses today are actively involved generating and 
publishing best cost effective evidences in order to improve the care and expand  
nursing knowledge .Nurses and other health care professionals can positively 
influence  patient care by incorporating the evidences on  practices of an oral care 
protocol improving consistency of care while promoting an intervention of proven 
benefits against oral mucositis. This motivated the researcher to identify the best cost 
effective, non irritating mouth rinse to alleviate the mucositis associated morbidity  
and enhance the  uninterrupted treatment adherence.  
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              Effective oral hygiene  is a universal preventive strategy and should be 
considered part of good clinical practice. A growing body of evidence supports the 
value of reducing bacterial dental plaque relative to reducing oral mucositis.  oral 
mucositis is associated with significant morbidity that can lead to treatment delays 
and interruption and the use of significant health care resource. 
 
STATEMENT OF THE PROBLEM: 
 “A  study to assess the effectiveness of   povidone –iodine (2%) vs normal 
saline(0.9%) mouth rinsing on oral mucositis among patients receiving external 
radiation therapy for head and neck malignancy  from Devaki Cancer and Research 
Centre  at Madurai”. 
 
OBJECTIVES: 
 To  explore  the severity of oral mucositis  before and after providing  
povidone –iodine(2%) and normal saline(0.9%) rinses among  patients 
receiving external radiation therapy  for head and neck malignancies. 
 To find out the  effectiveness of povidone –iodine(2%)  mouth rinsing on oral 
mucosititis among the patients with  head and neck malignancies in 
experimental group I 
 To find out the  effectiveness of normal saline (0.9%) mouth rinsing  on oral 
mucositis among patient with  head and neck malignancies in experimental 
group II 
 To compare the post test level of oral mucositis  score between experimental 
group I and  II  
 To determine  the association between pre test  level of oral mucositis score of  
experimental group I with selected demographical variables(i.e (Age, sex, 
14 
occupation, marital status, education status, smoking ,tobacco chewing, betel 
nuts and pan or kutka chewing) 
 To determine the association between pre test level of oral mucositis score of  
experimental group II with selected  demographical variables(i.e (Age, sex, 
occupation, marital status, education status, smoking ,tobacco chewing, betel 
nuts and pan or kutka chewing). 
 
HYPOTHESES: 
               All the hypotheses were tested at 0.05 level of significance 
H1: The mean post test oral mucositis score of patient with oral mucositis who 
receives povidone –iodine (2%)   mouth rinse will be significantly lower than 
the mean pretest  oral mucositis score of patient in  experimental group I 
H2:  The  mean post test  oral mucositis score of patient with oral mucositis who 
received normal saline (0.9%)  will be significantly lower than mean pretest  
oral mucositis score of patient in  experimental group II 
H3: There will be a significant difference between the mean post test level of  oral 
mucositis score of experimental group I who received  the povidone –iodine 
(2%) and experimental group II who received the normal saline (0.9%)  mouth 
rinse. 
H4: There will be significant association between  pretest  oral mucositis score, 
among patient who received  povidone –iodine (2%)   mouth rinse with selected 
variables (Age, sex, occupation, marital status, education status, smoking, 
tobacco chewing, pan ,betel nuts chewing). 
H5: There will be a significant association between the post test  oral mucositis  
score among patient who received normal saline (0.9%) rinse with selected 
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variables (Age, sex, occupation, marital status, education status, smoking, 
tobacco chewing, pan ,betel nuts chewing). 
 
OPERATIONAL DEFINITIONS: 
a) Effectiveness:    
Effectiveness is the capability of producing  a desired results. In this study, it 
refers to   povidone –iodine (2%)  and normal saline (0.9%)  mouth rinse in  reducing  
oral mucositis among the patient who received external radiation  therapy which was 
measured by score obtained by the subjects in oral mucositis assessment 
scale(OMAS). 
 
b) Povidone –iodine (2%): 
It has a bactericidal action and is effective against a wide range of bacteria, 
fungi and even spores. The killing action of vital cytoplasmic substrates, which are 
necessary for bacterial viability. In this study, it refers to the subjects who were 
treated with commercially available 10ml of povidone –iodine (2%) mouth rinsing 
after routine  brushing and before bedtime by  swishing motion for 2 minutes, this 
group was termed as experimental group I. 
 
c) Normal saline(0.9%): 
           Normal saline (0.9%) is a harmless bland isotonic oral rinse which has been 
shown to be beneficial in maintaining appropriate oral hygiene due to its safety, 
lowest toxicity and physiologic properties. In this study, it refers to the subjects who 
was treated with commercially available 20ml of normal saline(0.9%) mouth rinsing 
after routine  brushing and before bedtime by  swishing motion for 2 minutes, this 
group was  termed as experimental group II. 
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d) Mouth Rinse: 
            An antiseptic solution intended to cleanse, reduce, the microbial load and to 
treat the disease of mucosa in the oral cavity. In this study, mouth rinsing refers to 
rinsing of mouth with   povidone –iodine (2%) and normal saline (0.9%)  after routine 
brushing and before bedtime using, swishing motion for 2 minutes for a twice day . 
 
e) Oral Mucositis: 
   Marianna sampaio serpa,(2012) defined oral mucositis  as an inflammation  of  
oral      mucosa  resulting   from   cancer  therapy  typically  manifesting  an  atrophy,  
swelling,  erythema  and  ulceration. 
          In  this  study  mucositis  refers  to  the    mucosal  lesion  of  erythema  and  
ulceration   caused  by  radiation  therapy  as  measured  by  OMAS. 
 
f) Head and Neck Malignancies: 
      The  term  head  and  neck  malignancies  refers  to  a  group  of  biologically  
similar  malignancies  originating  from  the  upper   digestive  tract,  including  lip,  
oral  cavity,  mouth,  para  nasal  sinus,  pharynx,  larynx  and  pituitary  gland. 
 
g) External radiation therapy: 
Radiation   therapy  is  the  emission  and  distribution  of  energy  through    
space  or  material  medium.  The  energy  produced   by  radiation,  when   absorbed  
into  tissue,  produces  ionizing  and  excitation.  This  local  energy  is  sufficient  to  
break  chemical  bonds  in DNA  which  leads  to  biological  effect. 
In  this  study  it   refers  to  patients  who were diagnosed  with  head  and 
neck cancer  undergoing  treatment by external  radiation  therapy by  linear  
acceleration  in    Devaki   Cancer and Research Centre,  at  Madurai during  data  
collection   period. 
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ASSUMPTIONS 
1. Oral mucositis associated  with  significant  morbidity  that can lead to dose 
reduction, interruption and non compliance to treatment regimen. 
2. Assessment of oral mucositis is an important function of an oncology nurse. 
3. Vigilant observation and meticulous mouth care is necessary for intact 
mucosal lining adherence. 
4. Level  of mucositis will differ from one individual  to other 
 
DELIMITATIONS:    
                The following delimitation was set for the study.  
1. Patients with head and neck cancer who have completed 7sitting of  external 
radiation therapy, attending Devaki Cancer and Research Centre, at Madurai. 
2. The data collection period was 6weeks only. 
3. The evaluation of oral mucositis level was assessed 7th and 14th day after 
administration of selected mouth rinses. 
 
PROJECTED OUTCOME: 
           The study findings will help the nurses to determine the need for regular oral 
assessment of cancer patients on radiation therapy and help to select appropriate 
mouthwash to reduce oral mucositis. 
 
CONCEPTUAL FRAME WORK: 
            The study is based upon the J.W. kenny‟s  open system model. All the living 
systems are open in that there is a continual exchange of matter, energy and 
formation. The main concepts of the system model are input, throughput, output and 
feedback. 
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 Input: 
          Input refers to matter, and information that enters into the system through the 
boundary. In this study, the study the input refers to mouth wash given using 
povidone –iodine(2%) and normal saline (0.9%)  to experimental group I  and II 
respectively. 
 
 Through put: 
       Through put refers to the process where the system transfers energy, matter and 
information. In this study, through put refers to mucosoitis healing process, by the use 
of  povidone –iodine(2%) and normal saline (0.9%)   mouth rinse in experimental 
group I  and II. 
 
 Output: 
       Output refers to matter, energy and information that are processed. In this study, 
output refers to the sample that in group I and II will have an adequate healing after 
using povidone –iodine(2%) and normal saline (0.9%)   mouth rinse. 
 
 Feed back: 
         After processing the input, the system send output (matter, energy & 
information) to in alter state .Feedback refers to environment response  to the systems 
output using system‟s  adjustment, correction and accommodation to the interaction 
with the environment. In this study, it used; if there is inadequate wound healing 
feedback should be given and the sample should undergo assessment process. 
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CHAPTER II 
REVIEW OF LITERATURE 
 
A literature review is a text of a scholarly paper, which includes the current 
knowledge including substantive findings, as well as theoretical and methodological 
contributions to a particular topic.(Lamb and David,2014)    
 
  The literature is classified under the following headings. 
1. Literature related to incidence of oral mucositis among subjects with radiation  
therapy. 
2. Literature related to oral mucositis assessment. 
3. Literature related to povidone –iodine and normal saline mouth rinse. 
4. Literature related to role of nurse in care of patient with oral mucositis . 
 
 Literature related to incidence of oral mucositis among  subjects with radiation  
therapy: 
          Steven Peter Saldanha and Victoria Almeida (2014) stated that mucositis is the 
painful inflammation and ulceration of the mucous membrane, usually as an adverse 
effect of chemotherapy and radiation treatment for cancer. Radiotherapy to the head 
and neck or to the pelvis or abdomen is associated with the occurrence of oral 
mucositis, often exceeding 50% of patients. Among patients undergoing head and 
neck radiotherapy, pain and decreased oral function may persist long after the 
conclusion of therapy. Fractionated radiation dosage increases the risk of mucositis to 
>70% of patients in most trials. 
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         Elting, Cooksly and  Cambers (2007)  conducted a retrospective cohort study, 
on risk, outcomes, and costs of radiation-induced oral mucositis among patients with 
head-and-neck malignancies which consisted of 204 consecutive head-and-neck 
cancer patients who received Radiation Therapy with or without chemotherapy during 
2002.Results showed that Oral mucositis occurred in 91% of patients; in 66% it was 
severe (Grade 3-4).  Patients with OM were significantly more likely to have severe 
pain (54% vs. 6%; p < 0.001) and a weight loss of > or =5% (60% vs. 17%; p < 
0.001).
4
 
         Trotti , etal., (2003) done a meta analysis to find out the mucositis incidence and 
severity associated outcomes among patients with head and neck cancer receiving 
radiation therapy with or without chemotherapy. thirty-three studies (n=6181 patients) 
met inclusion criteria.The mean incidence was 80%. Over one-half of patients (56%) 
who received altered fractionation RT (RT-AF) experienced severe mucositis (grades 
3-4) compared to 34% of patients who received conventional RT. Rates of 
hospitalization due to mucositis, reported in three studies (n=700), were 16% overall 
and 32% for RT-AF patients. Eleven percent of patients had RT regimens interrupted 
or modified because of mucositis in five studies (n=1267) reporting this outcome. 
They concluded that mucositis is a frequent, severe toxicity in patients treated with 
radiation therapy for head and neck cancer. Recommended to find out the over all 
impact on all comes related investigation. 
         Talita Ribeiro and Tenório(2012) described chemotherapy-induced mucositis 
usually develops within 4–7 days after initiation of treatment and peaks within 2 
weeks. Radiation-induced mucositis typically begins at cumulative doses of about 15 
Gy (after about 10 days) and typically reaches full severity at 30 Gy, and lasts for 
weeks or even months . Patients with oral mucositis are significantly more likely to 
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experience severe pain and weight loss. Severity of oral mucositis has been correlated 
with compromised swallowing function in patients, resulting in the requirement for 
feeding via a gastrostomy tube. 
        University of Pretoria (2010) explained  oral mucositis is a complication 
affecting many patients receiving chemotherapy, head and neck radiation and those 
undergoing bone marrow transplant therapies. Oral mucositis can develop from the 
direct effect of cytotoxic drugs on oral mucosa due to the rapid turnover of oral 
epithelium, although the pathogenesis is probably more complicated than that. Severe 
mucositis interfere with cancer therapy, the costs can be crippling, and in severe cases 
lead to discontinuation of cancer therapy. 
         Komaroff ,Nalysnyk and Zilberberg  (2003) did a study to assess the incidence 
of radiation induced Oral Mucositis . They described Oral mucositis impacts over 
400,000 cancer patients each year. Over 40% of cancer patients develop oral 
mucositis (OM) due to conventional chemotherapy. For patients undergoing 
conventional radiation therapy for head and neck cancer or bone marrow transplant, 
OM rates are as high as 97-100%. 
 
Literature related to oral mucositis assessment: 
William Bensinger ,Mark Schubert ,Kie-kian ang, David Brizel and Elizabeth 
Brown(2008) enlisted  the  oral Assessment Guide (OAG) is an example of a scale 
developed for routine use by nurses and other support staff. Eight different aspects of 
the oral cavity are assessed and assigned a point value from 1 to 3 based on whether 
these aspects are normal or show moderate to severe changes. This scale is primarily 
used to monitor patient status and trigger interventions when oral health worsens. 
However, the key issue is to consistently use an accepted grading scale throughout 
treatment. 
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             Crispian Scully and Joel Epstein(2004) explained the two most commonly 
used scoring tools are the World Health Organization (WHO) and the National 
Cancer Institute  common toxicity criteria (NCI-CTC). The WHO scale is the most 
widely used and includes criteria which are objective (presence of erythema and 
ulceration), subjective (oral pain), and functional (patient’s ability to eat) to determine 
an overall score. A number of additional scales have been developed to be used as 
nursing or research tools. The choice of mucositis scoring should depend on the 
specific need of assessment, with different scales used for clinical patient care and for 
mucositis research. Validation of mucositis scales is required for use in research 
protocols; one recently validated scale, the Oral Mucositis Assess ment Scale 
(OMAS) has examined utility in a multicenter study, assessing inter examiner and 
intra examiner reliability, and it represents the only validated mucositis scale that 
separates mucosal damage from symptoms and oral function. 
         Oral Mucositis Assessment Scale was designed by Sonis et al. (1999). It is a 
valid, reliable and easy to use scale which separates the objective from the functional 
measurements and can be used by people with minimal training in large scale multi-
site clinical trials. The objective measurement divides the mouth into 9 different 
anatomical areas and gives each a score from zero to three for ulceration and zero to 
two for erythema. Degree of ulceration and redness in the mouth are primary 
indicators of OM while oral pain, difficulty in swallowing, and the ability to eat are 
taken as secondary indicators. A single score is not produced from this scale, rather a 
score for ulceration and redness based on different locations in the mouth are used. 
             Malays and Med sci(2008) described that there are many mucositis 
assessment scales available and some are still under development worldwide. As the 
scale have been used by radiation oncologists, medical oncologists, head and neck 
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surgeons, haematologists, somatologists, dentists and nurses, the variability of the use 
of a particular scale is inevitable. However a unified mucositis tool could be of 
immense value in a multidisciplinary set up or for inter- institutional comparisons. 
The most popular mucositis scales are radiation therapy oncology group for 
radiotherapy, World Health Oraganization for chemotherapy, common toxicity 
criteria of  National Cancer Institute for chemotherapy and radiotherapy. Oral 
mucositis assessment scale is a recent tool developed to evaluate detail anatomical 
sites of mucositis and may be appropriate for multidisciplinary healthcare teams. 
               Medeiros and sixous (2011) says that a wide variety of scales have been 
used to record the extent and severity of  oral mucositis in clinical practice and 
research. The world health organization scale is simple, easy to use and is suitable for 
daily use in clinical practice. This scale combines both subjective and objective 
measures of oral mucositis. The National Cancer Institute(NCI) common terminology 
criteria for adverse events(CTCAE) version 3.0 includes separate subjective and 
objective scales for mucositis. The oral mucositis assessment scale is an objective 
scale, suitable for research purposes, the measures erythema and ulceration at nine 
different sites in the oral cavity. This scale has been validated in a multicenter trial 
with high inter-observer reproducibility and strong correlation of  objective mucositis 
scores with patient symptoms.  
 
Literature related to povidone –iodine and normal saline mouth rinse: 
Wong ,Dodd and Paul (2006) conducted a study in San Francisco general 
hospital ,USA to determine the pattern, severity, and time course of Radiation 
Therapy induced mucositis pain; self-care behaviours (SCBs) used to manage 
mucositis pain; and the effectiveness of these behaviours in relieving such pain. 
Forty-nine patients   with mucositis were assessed using the MacDibbs Mouth 
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Assessment Tool to determine the severity of Radiation Therapy induced mucositis 
pain over their course of Radiation Therapy and at a one-month follow-up visit. All 
patients developed pain due to Radiation Therapy -induced mucositis. A Self-Care 
Diary was used weekly by patients to record SCBs and their effectiveness. The most 
effective SCBs  for RT-induced mucositis pain were mouth rinsing and using oral 
analgesics. 
         Madan  Kumar and  Sequeira
 
(2008) done  a Study  to see the effect of three 
test mouthwashes and a control were studied. 0.12% chlorhexidine, 1% povidone-
iodine, Salt/sodium bicarbonate, Plain water (control) Coloring agents, sweeteners, 
and flavoring agents were added to the mouthwashes so that all had identical color 
and taste. All were alcohol free, 76 completed Compliance was assessed weekly by 
WHO oral assessment scale .Significant difference in mean mucositis scores were 
observed among all four groups. Post hoc analysis for repeated measure showed a 
statistically significant difference between the povidone group and control group (p = 
0.013) at the end of week 1.At the end of week 2, povidone, chlorhexidine and 
salt/soda groups differed significantly from the control group at end of week 4, 
significant difference also were observed between the povidone and salt/soda groups 
(p =0.16). Thus the study concluded that all the 3 mouthwashes were effective in 
reduction of mucositis. 
             Kamalaksha Shenoy(2008)  demonstrated that the use of alcohol-free 
povidone-iodine mouthwash can reduce the severity and delay the onset of oral 
mucositis due to antineoplastic radiotherapy, thus improving the quality of life for 
patients. Hence, use of alcohol-free povidone-iodine mouthwash can be advocated for 
patients' use during radiotherapy.  
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          Miller and Kearney (2001) explained that the mainstay of an effective oral care 
regimen is mouth rinses, and just plain salt water is one of the best and most cost 
effective mouth rinses available. A mouth rinse aides in removing debris and keeping 
the oral tissue moist and clean. Good oral care, defined as frequently rinsing the 
mouth with saline, may help prevent mouth sores Salt mouthwash can soothe the pain 
and keep food particles clear so as to avoid infection. Normal saline (o.9%) is a non 
irritant and is believed to help in formation of granulation tissue and to promote 
healing. Its safe, economical and readily available mouthwash, the use of  can be 
promoted. 
              Samuel Vokurka , Eva Bystřick and Vladimír Koza(2005) done a 
comparative Study  to see the effectiveness of povidone-iodine with normal saline in 
Radiation and chemotherapy  induced  oral mucositis.  Study was done with 132 
patients  by  randomization to use normal saline (n=65) or povidone-iodine diluted 
1:100 (n=67) mouthwashes for OM prophylaxis and treatment after high-dose 
chemotherapy comprising BEAM or HD-L-PAM followed by autologous peripheral 
stem cell transplantation.  Difference was found between the groups in respect of OM 
characteristics. The antimicrobial solution was less tolerable for patients. OM 
occurred significantly more often in females than in males (86% vs 60%, P=0.0016) 
and was worse and of longer duration. The study recommended while selecting  oral 
rinses, the patient’s individual preference and tolerance of solutions offered should be 
considered. 
              Hashemi and Bahrololoumi (2015) says that  normal saline (sodium chloride 
0.9% solution) is a harmless bland isotonic oral rinse which has been shown to be 
beneficial in maintaining appropriate oral hygiene due to its safety, lowest toxicity 
and physiologic properties. Although there are several studies on the preventive effect 
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of normal saline on oral mucositis in chemotherapy, radiotherapy and/or 
hematopoietic stem cell transplantation patients, few studies have assessed its effect 
on prevention of mucositis resulting from chemotherapy . Actually, in one of the 
mentioned studies normal saline showed inferior effect on preventing chemotherapy 
induced mucositis compared to chlorhexidine and cryotherapy. In the other one, 
normal saline was less effective in preventing chemotherapy induced mucositis in 
comparison to honey plus normal saline and placebo groups. 
              Berry and Davidson ( 2006) described that there is some evidence that the 
use of physiological salt solution can promote healing of oral mucosal lesions. 
Saldanha and Almeida (2014) evaluated the efficacy of turmeric in preventing 
radiation induced oral mucositis in patients receiving head and neck cancer which 
showed that when compared with the cohorts using povidone-iodine gargle, the group 
using turmeric as a mouth wash had delayed and reduced the levels of radiation-
induced oral mucositis and was statistically significant at all time points (:<0.001 to 
:<0.0001). Additionally, the cohorts using turmeric had decreased intolerable 
mucositis (:<0.001) and lesser incidence of treatment breaks in the first half of the 
treatment schedule before 4 weeks (:<0.01) and reduced change in body weight 
(:<0.001).Gargling with turmeric by head and neck cancer patients undergoing 
radiation therapy provided significant benefit by delaying and reducing the severity of 
mucositis. In the present study paired t - test was computed at a level of 0.05 
significance between pre intervention on day 1 and post-intervention day 5 and found 
that the calculated t value(t=17.81) was significantly greater than the tabled 
value(t=2.093) indicating turmeric mouth wash is effective on radiation induced oral 
mucositis .  
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            Worthington , Clarkson and Eden (2007) conducted a study to evaluate of the 
effectiveness of prophylactic agents for oral mucositis in patients with cancer 
receiving treatment, compared with other potentially active interventions by using 
Cochrane data base system review. Two hundred and seventy-seven studies were 
eligible. One hundred and eighty-eight were excluded for various reasons, usually as 
there was no useable information on mucositis. Of the 89 useable studies all had data 
for mucositis comprising 7523 randomized patients. Interventions evaluated were: 
acyclovir, allopurinol mouth rinse, aloe vera, antibiotic pastille or paste, 
benzydamine, beta carotene, calcium phosphate, camomile, Chinese medicine, 
chlorhexidine, etoposide, folinic acid, glutamine, granulocyte/macrophage colony-
stimulating factor (GM-CSF), histamine gel, honey, hydrolytic enzymes, ice chips, 
iseganan, keratinocyte GF, misonidazole, pilocarpine, pentoxifylline, povidone, 
prednisone, propantheline anticholinergic, prostaglandin, sucralfate, systemic 
antibiotic clarithromycin, traumeel, zinc sulphate. Of the 33 interventions included in 
trials, 12 showed some evidence of a benefit (albeit sometimes weak) for either 
preventing or reducing the severity of mucositis. Interventions where there was more 
than one trial in the meta-analysis finding a significant difference when compared 
with a placebo or no treatment . 
              Caballero,Lagares and Garcia(2012) conducted a study in Spain on Cancer 
treatment-induced oral mucositis which  stated that  Head and neck cancer represents 
one of the main oncological problems. RT and CT leads to mucositis, and other side 
effects. The authors reviewed high-quality evidence published over the last 25 years 
on the treatment of cancer treatment-induced oral mucositis. A Medline search for 
double blind randomized controlled clinical trials between 1985 and 2010 was carried 
out.  The different therapeutic approaches found for cancer treatment-induced 
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oral mucositis included: intensive oral hygiene care; use of topical antiseptics and 
antimicrobial agents; use of anti-inflammatory agents; cytokines and growth factors; 
locally applied non-pharmacological methods; antioxidants; immune modulators; and 
homoeopathic agents. To date, no intervention has been able to prevent and treat 
oral mucositis on its own. 
 
Literature related to role of nurse in care of patient with oral mucositis: 
           According to Ministry of Health (2004)  oral care is important for patients 
health and well- being for a variety of reason. Not only is the mouth vital for eating, 
drinking, breathing, verbal and non- verbal communication, saliva also has 
antibacterial properties and is part of the body’s defense against infection. 
          Rebecca Hogan(2013) says that  oral mucositis is a debilitating side effect that 
has much clinical significance. Oral mucositis may decrease the effectiveness of 
treatment as well as decrease the quality of life in the oncology patient. Therefore, it 
is our responsibility as health care professionals to reduce the incidence and or 
severity of mucositis as much as possible. One intervention that has been proven to be 
successful is basic oral hygiene implemented through an oral care protocol. It is 
important that nurse are educated on the significance of adequate dental hygiene and 
the process and need for institutional change protocols. Nurses and other health care 
professionals can positively influence patient care by incorporating the evidence 
based practice of an oral care protocol improving consistency of care while promoting 
an intervention of proven benefits against oral mucositis.  
           Avritscher et al.,(2004) explained that oncology nurses have the potential to 
serve a pivotal role in the advancement of the state of the art and knowledge of the 
treatment and prevention of mucositis in patients receiving cancer treatment. 
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            Latino (2015) described that nurse pay role in providing oral care education 
for patients. The latest clinical practice guidelines for preventing and treating oral 
mucositis recognize the importance of excellent oral care before and during cancer 
treatment. Diligent oral hygiene and treatment of pre-existing oral or dental 
conditions prior to cancer therapy may help reduce the risk and severity of oral 
mucositis. 
              Loke Bikram Thapa (2007) explained that the nurse assesses the patient’s  
skin , nutritional status, and general feeling of well being.  The skin and oral mucosa 
are assessed frequently for changes. The skin protected from irritation, and the patient 
is advised to avoid using ointments, lotions or powders on the area. Gentle oral 
hygiene is essential to remove debris, prevent irritation, and promote healing. If 
systemic changes such as weakness and fatigue occur, the patient may need assistance 
with activities of daily living and personal hygiene. 
         Haberman (2000) described that oncology nurses have key roles as caregivers, 
as well as providers of patient and family education, in clinical cancer research, in 
health care administration, and as advanced oncology nurse practitioners. Cancer 
nurses also are continuously involved in the enhancement of nursing practice through 
research, continuing education, and advanced education. 
         Henke (2001) says that Oncology nurses are challenged on a daily basis to deal 
with the numerous symptoms patients with cancer and their families encounter as a 
result of their cancer or its treatment. Nurses triage patient  Problems and assist in the 
evaluation of symptoms and initiation of interventions. 
        Higgins (2000)explained that the oncology nurses plays a vital role in 
coordination the multiple and complex technologies now commonly employed in 
cancer diagnosis and treatment. This coordination encompasses direct to patient care, 
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documentation in the medical record, participation in therapy, symptom management, 
organization of referrals to other healthcare providers, both patient and family 
education, as well as counseling throughout diagnosis, therapy, and follow-up. 
       Bruner and Haas (2006) described that the nurse plays an important role in 
identifying, reporting, and helping patients deal with the side effects of radiation and 
chemotherapy. Educating patients about their treatment regimen, supportive care 
options (e.g antiemetics, antidiarrheals), and what to expect during the course of 
treatment is important to help decrease fear and anxiety, encourage adherence, and 
guide at- home self-management. Before initiating education, however, the patient’s 
ability and desire to process information should be assessed. Teaching should then be 
customized to meet the patient’s and family’s learning needs. 
           Rubenstein and Shubert (2004) says that oral assessment and meticulous 
intervention to keep the oral cavity moist, clean, and free of debris are essential to 
prevent infection and to facilitate nutritional intake. The patient should be taught to 
self- examine the oral cavity. The mucous membranes, characteristics of saliva, and 
ability to swallow must be assessed. Oral care includes pretreatment evaluation by a 
dentist to perform all necessary dental work before the initiation of treatment. The 
patient should also be taught how to perform oral care (proper tooth brushing, 
flossing, and use of fluoride trays to prevent caries). Oral care should be performed at 
least before and after each meal and bedtime. 
          Cuncins-hearn and Saunders(2004) explained that Self- care instruction for 
patients receiving radiation are provided to assist in the maintenance of skin integrity 
during the treatments and for several weeks after completion. Follow- up care 
includes teaching the patient to minimize sun exposure to treat area and reassuring the 
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patient that minor twinges and shooting pain in the breast are normal after radiation 
treatment. 
          It can be concluded from above literature review frequent oral assessments are 
particularly important in the setting of radiation therapy and chemotherapy to detect 
and monitor oral mucositis progression. Povidone-Iodine and Normal saline mouth 
rinses are found to be effective in reducing the severity and delay the onset of oral 
mucositis due to radiation therapy among patients with Head and Neck Cancer. 
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CHAPTER-III 
RESEARCH   METHODOLOGY 
 
       “Research methodology is a way to systematically solve the research problem. 
The techniques used to structure a study and to gather and analyze information in a  
systematic fashion” (University  of  Toronto -2002) 
             This chapter includes the research approach research design, population, 
sample and criteria for the sample selection. It further deals with the development of 
tool, procedure of data collection and plan for data analysis. 
 
RESEARCH APPROACH:  
Quantitative research approaches were used to check the effectiveness of 
povidone-iodine (2%) and  normal saline (0.9%) rinsing 
 
RESEARCH DESIGN: 
                A quasi experimental with pretest, post test two experimental group design 
were used. 
                In this both the experimental group were exposed for pretest and post test. 
                The research design is represented in the below table. 
 
GROUP PRE TEST TREATMENT 
POST TEST 
7
th
 day 14
th
  day 
Experimental Group I 01 X1 O2 O3 
Experimental Group II 01 X2 O2 O3 
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KEYS: 
O 1- Pretest level of oral mucositis among experimental group I  and experimental 
group II 
O 2- Post test level of oral mucositis among  experimental group I and II on 7
th
 day. 
O3 - Post test level of oral mucositis among  experimental group I and II on  14
th
 day. 
X 1- Mouth rinse with povidone-iodine(2%) 
X 2- Mouth rinse with normal saline (0.9%)   
 
VARIABLES: 
 Independent variables: Povidone iodine(2%)  and normal saline (0.9%)  mouth 
rinse 
 Dependent variable: Level of oral mucositis  
 
SETTING OF THE STUDY: 
             This study was conducted at Devaki Cancer and Research Centre, Arasaradi, 
at Madurai. It is 7.6km away from the Sacred Heart Nursing College, Madurai. This 
hospital provides all specialized care of all type of cancer and cancer patients on 
inpatients and out patient basis. The treatment include chemotherapy and radiation 
therapy, brachy therapy and teletherapy with the help of linear acceleration therapy. 
The total census of cancer patients in Devaki Cancer and Research Centre was 200 
per day among them 150-160 patients undergoing radiation therapy and 100-110 
patients were receiving external radiation therapy. 
 
STUDY POPULATION: 
             The target population of the study subjects were patients receiving external 
radiation therapy for head and neck malignancies in Devaki Cancer and Research 
Centre at Madurai. 
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SAMPLE: 
           The sample of the study were patients with head and neck cancer who have 
developed oral mucositis and subject who fit into the inclusion criteria, in Devaki 
Cancer  and Research Centre during data collection period. 
 
SAMPLE SIZE: 
            The total sample size for the study was 60, among this 30 patients were 
assigned to experimental group I and 30 patients were assigned to experimental   
group II. 
 
SAMPLING TECHNIQUE: 
                Sampling  is the process of selection a representative part of the population 
in the study(Sharma, 2012) 
               The simple random sampling technique was used by lottery method from the 
radiation department register maintained in Devaki Cancer and Research Center, at 
Madurai.  
 
CRITERIA FOR SAMPLE SELECTION: 
            The samples were selected based on the following inclusion and exclusion 
criteria 
Inclusion criteria: 
 Patients  with head and neck malignancies aged 18 years and above 
 Patients who have received radiation therapy for minimum of  7 sitting . 
 Both male and female patients with mild to moderate level of oral mucositis as 
per oral mucositis assessment scale. 
 Patients who are willing to participate. 
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 Exclusion criteria: 
 Patients who are not willing to participate 
 Patients  who are not able to follow the instruction 
 Patients with HIV infection,  oral candidiasis, herpes simplex infection 
 Patients using any other prophylactic mouthwashes. 
 Patients who suffers with known allergic to povidone-iodine(2%) and normal 
saline(0.9%). 
 Patients with severe oral mucositis as per OMAS  
 
RESEARCH TOOL AND TECHNIQUE: 
The instrument which was used in this study has two parts. 
 Part I: 
(a)Demographic profile: 
In  consists of demographic  profile such as age, education, occupation, 
marital status, history of betel, nuts, or tobacco chewing, smoking, pan or kutka 
chewing 
 
(b) Clinical profile: 
 Location of  the tumor ( lip, oral cavity, mouth, pharynx, larynx, primary 
tumor, pituitary gland, salivary glands and nasal cavity) 
 Severity of the tumor( tumor, node involvement, metastasis) 
 Dose of radiation therapy per day (200-400 Gy) 
 
Part II – Instrument profile: 
Oral mucositis assessment scale is standardized tool. This tool was 
downloaded from internet at free of cost.  The validity and reliability of the tool was 
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examined. The tool separates the mucosal damage from symptoms and other oral 
function. 
 This tool has 9 items. The 9 items assessed in two different criteria i.e 
ulceration and erythema. Each item was scored between 0,1,2, and 3.  In  
ulceration 0 refers to no ulceration, 1 indicates less than 1cm, 2 indicates ulcer 
size from 1.1cm- 3 cm and scoring of 3 indicates above 3.1cm. 
 In erythema 0 refers to no erythema, 1 refers to non- severe erythema and 2 
refers to severe erythema. Based on the scores obtained the subject grouped 
into various categories. 
 
SCORING PROCEDURE 
The total score of  27 was categorized in ulceration and 18 was categorized  in 
erythema. 
 In  ulceration the Score between 1-9 falls under mild ulceration, and between 
10-18 is categorized as a moderate ulceration and scoring of 19- 27 is 
categorized under severe ulceration.  
 In  erythema 1-9 scores are categorized as not a severe erythema and 10-18 
categorized as a severe erythema. 
 
Ulceration Erythema 
Categories Scoring Total Categories Scoring Total 
No ulcer 
Mild 
Moderate 
Severe 
0 
1 
2 
3 
0 
1 – 9 
10 – 18 
19 – 27 
No erythema 
Not severe 
Severe 
 
0 
1 
2 
0 
1 – 9 
10 – 18 
 
38 
TESTING OF TOOL: 
Validity: 
              To evaluate the content validity of the tool, the tool was submitted to seven 
experts. Five experts from the field of medical surgical nursing and two experts from 
the field of radiation oncology. Validation of the tool were based on their suggestions. 
 
Reliability: 
            Reliability of the tool was obtained by inter rater method. Karl pearson`s              
co-efficient of correlation method were  used to find out reliability. The reliability of  
oral mucositis assessment scale for ulceration r = 0.99, for erythema r = 0.94. This 
tool was found  to be highly reliable. 
 
DEVELOPMENT OF INTERVETION: 
                   The intervention strategy was based on review of literature. The amount 
of povidone –iodine(2%) and normal saline (0.9%)   selected for mouth rinsing was 
decided based on expert opinion. 
 
STEPS OF INTERVENTION: 
DEFINITION: 
A medicated solution used to cleanse or treat the disease of oral mucositis. 
 
PURPOSES: 
 To prevent the mucosal damage  
 To reduce the oral micro flora 
 To promote re-epithelization of soft tissue 
 To reduce the pain  
 To relieve the discomfort 
 To enhance the sense of well being and comfort 
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ARTICLES: 
 Face towel 
 Tumbler or feeding cup containing water to wash the face 
 Mouth rising solution 
a. Povidone-iodine(2%) for experimental group I 
b. Normal saline(0.9%) for experimental group II 
 K-basin or emesis basin 
 Measuring cup or ounce glass 
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STEPS  OF PROCEDURE 
NURSING ACTION FOR 
EXPERIMENTAL  GROUP I 
NURSING ACTION FOR 
EXPERIMENTAL  
GROUP II 
RATIONALE 
  
1. Inspect the lips (upper and lower) 
buccal mucosa (right and left) soft 
and palate, tongue (dorsal and ventral 
floor of the tongue. 
 
2. Explain the procedure to the 
patient. 
3.Measure 10ml of mouth rinse 
(Povidone-iodine 2%) for 
experimental group I 
4.Allow the patient to rinse mouth 
with Povidone-iodine(2%) by 
swishing motion for 2 minutes. Make 
the patient to  ensure rinsing should 
cover all mucosal lining of the oral 
cavity. 
 
5. Receive the waste in k-basin or ask 
the patient to spit in a wash basin. 
 
6. Assist the patient to wipe the face 
with face towel. 
7.  Ask the patient to record the time 
of procedure. 
      Instruct the patient that the same 
techniques should be repeated in a 
night time also. 
  
1. Inspect the lips(upper and 
lower) buccal mucosa(right 
and left) soft and palate, 
tongue(dorsal and ventral 
floor of the tongue. 
2. Explain the procedure to 
the patient. 
3.Measure 20ml of mouth 
rinse(Normal saline 0.9%) for 
experimental group II 
4.Allow the patient to rinse 
mouth with Normal saline 
0.9% by swishing motion for 
2minutes.Make the patient 
ensure mucosal rinsing should 
cover all lining of the oral 
cavity. 
5 .Receive the waste in k-
basin or ask the patient to spit 
in a wash basin. 
6. Assist the patient to wipe 
the face with face towel. 
7.Ask the patient to record the 
time of procedure 
Instruct the patient that The 
same techniques should be 
repeated in a night time also. 
 
1. Determine the status 
of oral mucosa. 
 
 
 
2. Reduce the anxiety 
and promote patient 
participation. 
3.Swishing motion helps 
to remove the debris and 
oral micro flora 
 
4.Promote sense of 
comfort 
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PILOT STUDY: 
In order to find out the feasibility of the study, pilot study was conducted in 
similar manner of the original study among 6 patients , three in the experimental 
group I and in experimental II study was conducted  in subjects who were staying in 
Deveki Cancer and Research Centre, Madurai.  The study was found to be feasible. 
The pilot study participants were excluded from the main study. 
 
DATA COLLECTION PROCEDURE: 
After obtaining a ethical committee approval, a formal permission from  
Devaki Cancer and Research Centre and informed consent  from study subjects the 
data collection procedure was proceeded. The total number of 60 samples were 
chosen by using purposive sampling techniques.  30 samples were assigned to 
experimental group I and 30 samples were assigned to experimental group II. Pretest 
level of oral mucositis was assessed by using oral mucositis assessment scale. After 
collecting the pretest steps of mouth rinsing was demonstrated by the researcher. The 
study subjects of experimental group I was instructed to rinse the oral cavity with 
10ml of povidone iodine 2%without dilution respectively for 2 minutes, and the 
experimental group II to rinse the oral cavity with 20 ml of  Normal saline 0.9%   for 
2 minutes  after their regular brushing in the morning  and before  going to bed in 
night  (a twice day ). The subjects were provided with measuring a cup to measure the 
quantity of oral rinse. Each subjects were received the information about mouth 
rinsing technique. Then the researcher ask the study subjects  to  maintain the diary 
indicating the time for mouth rinsing .This was  continued for 14 days.  Level of oral 
mucositis among all subjects were examined at the end of 7
th
 day and 14
th
 day during 
their radiation therapy schedule. 
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PROTECTION OF HUMAN SUBJECTS: 
           Research proposal was approved by dissertation committee of sacred heart 
nursing college, Madurai. Permission was obtained from Devaki Cancer and Research 
Centre, prior to study. Informed written consent taken from each subjects was 
obtained before starting data collection. Assurance was given to the subjects, that 
confidentiality will be maintained. The subjects were explained that they have rights 
to withdraw from study. There was absence of physical and psychological strain to 
study subjects. 
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CHAPTER- IV 
ANALYSIS AND INTERPRETATION OF DATA 
 
            The fourth chapter deals with description of samples, classification, analysis 
and interpretation of data collected to evaluate the achievement of the objectives of 
the study and discussion of the study findings, a data is tabulated and described as 
follows. 
 
PRESENTATION OF THE FINDINGS OF STUDY 
Section I 
 Demographic characteristics of the sample. 
 
Section II 
 Frequency and percentage distribution of sample according to oral mucositis. 
 Frequency and percentage distribution of sample according to oral mucositis  
before and after the use of povidone iodine mouth rinsing in experimental 
group I. 
 Frequency and percentage distribution of sample according to oral mucositis  
before and after the use of normal saline mouth rinsing in experimental              
group II. 
 
Section III 
 Comparison of mean oral mucositis score among the experimental group I 
before and after use of povidone iodine mouth rinse. 
 Comparison of mean oral mucositis score among the experimental group II 
before and after use of normal saline mouth rinse. 
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 Comparison of mean post test oral mucositis score among the experimental 
group I and II  after use of povidone iodine and normal saline mouth rinse. 
 
Section IV 
 Association between oral mucositis score of the experimental group I and II  
with selected demographic variables. 
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SECTION – I 
 
Demographic variable of the samples: 
              This section deals with demographic variables of the subjects such as Age, 
Sex, Education, Occupation, and Marital status, History of smoking, tobacco, betel 
nut, pan (or) kutka chewing. 
 
TABLE 1:  
Frequency and percentage distribution of the subject with regard to 
selected demographic variables. 
                                                                                                                               N = 60 
Demographic              Experimental group I        Experimental group II 
Characteristic                      n= 30                                           n= 30 
                                         F                %                    F                   %                    Total % 
Age (in year) 
18 – 28                             -                   -                     -                    -                               - 
29 – 38                             6                 20                   4                  13.33              10      16.66 
39 – 48                           14               46.66               15                    50                29      48.33 
49 – 58                           10               33.33               11                 36.66              21        35 
Sex 
Male                               23               76.66               17                56.66              40       66.66 
Female                             7                23.33               13                43.33              20       33.33 
Education status 
Illiterate                          14                46.66               12                  40                 26      43.33   
Literature                        16                53.33               18                  60                 34      56.66 
Occupation 
Sedentary worker           19                 63.33               22                 73.33             41     68.33 
Moderate worker            11                 36.66                 8                 26.66            19     31.66 
                                                                                                                                                                                             
Table cont…… 
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                                                                                                                               N = 60 
Demographic              Experimental group I        Experimental group II 
Characteristic                      n= 30                                           n= 30 
                                         F                %                    F                   %                  Total % 
Marital status 
single                               -                   -                     -                    -                               - 
Married                          28              93.33                27                 90                   55      91.66 
Unmarried                        -                   -                     -                    -                               - 
widow                             2               6.66                   3                   10                    5        8.33                 
H/o smoking                    
Yes                               19              63.33                 12                  40                   31      51.66 
No                                 11             36.66                  18                  60                   29      48.33 
H/o betel nut chewing     
 Yes                             13               43.33                 14                46.66                 27      45 
 No                               17               56.66                 16                53.33                 33      55 
H/O pan/ kutka chewing 
Yes                                 1               3.33                     1               3.33                   2        3.33 
No                                 29              96.66                  29               96.66                 58     96.66 
  
 The data in table 1 shows that the most of the sample 14(46.66%) were between 
the age of 39-48 years in experimental group I and 15(50%) belongs to 39-48 years 
in experimental group II. 
 Regarding sex in both experimental group I and II majority of the samples were 
male 23(76.66%) and 17 (56.66%) respectively. 
 Regarding education status both experimental group I and II most of them were 
literate 16 (53.33%) and 18 (60%) respectively. 
 Regarding occupation majority of the samples are sedentary workers in both 
experimental group I  19 (63.33%)and in experimental group II   22(73.33%). 
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 Regarding marital status most of them are married in experimental group I  
28(93.33%) and in the experimental group II 27(90%) respectively. 
 With regards to smoking history most of them had the habits of smoking in 
experimental group I 19(63.33%) and in experimental group II 12(40%) 
respectively. 
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FIGURE 2: Distribution of the subject with according to age in experimental 
group I and experimental group II 
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Clinical profile of the samples 
                This section deals with clinical variables of the subjects such as location of 
the tumor, severity of the tumor, dose of radiation therapy per day. 
 
TABLE 2: 
           Frequency and percentage distribution of the subject with regard to 
selected clinical variables. 
                                                                                                      N = 60 
Demographic              Experimental group I           Experimental group II 
Characteristic                      n= 30                                    n= 30 
                                         F                %                    F                   %                     Total % 
Location of the tumor       
Lip                                   2              6.66                   1                   3.33              3               5 
Mouth                              4            13.33                   3                    10                7           11.66 
Pharynx                            8            26.66                 10                 33.33             18            30 
Larynx                             13           43.33                 14                 46.66             27            45 
Pituitary gland                  3              10                     2                    6.66              5            8.33 
Severity of tumor 
Tumor size(Tx – T4b)     20           66.66                 19                   63.33            39           65 
Node involvement           3               10                     1                 3.33                 4            6.66 
Metastasis                        7               23.33               10               33.33               17          28.33      
 
                                                                                                              Table cont…… 
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N = 60 
Demographic              Experimental group I        Experimental group II 
Characteristic                      n= 30                                           n= 30 
                                         F                %                    F                   %                    Total % 
Dose of  radiation therapy per day 
a) 100cGy                   -                   -                      -                   -                          - 
b) 200cGy                  30                30                   30                 30                      100 
c) 300cGy                   -                   -                      -                   -                           - 
d) 400cGy                   -                   -                      -                   -                           - 
 
 
 The data in table 2 shows that majority of the sample had cancer larynx, 
13(43.33%) in experimental group I and  experimental group II 14(46.66%). 
 Regarding severity of the tumor in both experimental group I and II majority 
of the samples had tumor size ranging from (Tx – T4b), 20(66.66%) and 19 
(63.33%)  
 Regarding the dose of radiation administered per day for all the 
samples(100%)in both experimental group I and II were similar in receiving 
dose of 200 cGy per day.    
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FIGURE 3: Distribution of the subject according to location of the tumor in 
experimental group I and experimental group II 
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SECTION –II 
Distribution of samples according to the level of oral mucositis 
TABLE 3: 
            Distribution of  subject according to the level of oral mucositis before and 
after use of povidone- iodine in experimental group I 
                                                                                                                              N = 30 
       
Data on table – 3 based on mucositis level obtained. The subjects were 
classified into 4 group. No ulcer (0), mild (1-9), moderate (10-18), severe (18- 30). A 
higher score indicate poor oral mucositis status, where as a low score indicate 
reduction in oral mucositis level. 
Table – 3 shows that before using of povidone- iodine mouth rinsing there was 
10(33.33%) clients had mild ulceration and 20(66.66%) clients had moderate 
ulceration. After povidone- iodine mouth rinsing, on 7
th
 day 22(73.33%) clients had 
Level of                                                                               
mucositis              
Experimental group I 
                                    Pre Test                          Post Test  
  7
th
 day                                    14
th
 day        
                                F                %                    F             %                       F                  % 
Ulceration 
No ulcer                   -                 -                       -               -                       10               33.33 
Mild                        10             33.33                  22           73.33                 18                 60 
Moderate                 20             66.66                   8            26.66                  2                6.66 
Erythema 
No erythema              -                  -                      4            13.33                  8               26.66 
Not severe                30               100                  26            86.66                 22             73.33 
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mild ulceration and 8(26.66%) clients had moderate ulceration, on 14
th
 day 
10(33.33%) clients had no ulcer, 18(60%) clients had mild ulceration and 2(6.66%) 
clients had moderate ulceration. For erythema  during pre test 30(100%) client had not 
severe erythema . After using of  povidone- iodine mouth rinsing, on 7
th
 day 
4(13.33%) clients had no erythema and 26(86.66%) clients had not severe erythema, 
on 14
th
 day 8(26.66%) clients had no erythema  and 22(73.33%) client had not severe  
erythema. This difference may be due to effect of povidone- iodone mouth rinsing. 
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FIGURE 4: Distribution of subjects according to oral ulceration status 
in experimental group- I 
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FIGURE 5 : Distribution of subjects according to oral erythema status 
in experimental  group- I 
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TABLE 4: 
     Distribution of subjects according to the level of  oral mucositis before and 
after use of normal saline in experimental group II. 
                                                                                                                   N =  30 
Level of                                                               
mucositis              
Experimental group II                            
Pre Test 
Post Test  
7
th
 day                                 14
th
 day  
                                F                %                    F             %                       F                  % 
Ulceration 
No ulcer                   -                 -                       -               -                        5                16.66             
Mild                        15              50                     21             70                     19               63.33 
Moderate                 15              50                     9               30                      6                  20   
Erythema 
No erythema              -                -                      3               10                      6                  20  
Not severe                30            100                   27               90                     24                80 
 
Table – 4 shows that before using of normal saline mouth rinsing there was 
15(30%) samples had mild ulceration and 15(30%) samples had moderate ulceration. 
After  using  of normal saline mouth rinsing, on 7
th
 day 21(70%) samples had mild 
ulceration  and 9(30%) samples had moderate ulceration, on 14
th
 day 5(16.66%) 
clients had no ulceration  and 19(63.33%) samples had mild ulceration  and 6(20%) 
samples had moderate ulceration. This is due to the effect of normal saline mouth 
rinsing. For erythema during pretest 30(100%) samples had not severe erythema, on 
7
th
 day 3(10%) samples had no erythema and 27(90%) samples had not severe 
erythema, on 14
th
 day 6(20%) samples had no erythema and 24 (80%) samples had 
not severe erythema. 
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FIGURE 6 : Distribution of subjects according to oral ulceration status 
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FIGURE 7 : Distribution of subjects according to oral erythema status 
in experimental  group- II 
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TABLE 5: 
            Distribution of subjects according to the post test level of oral mucositis in 
experimental group I and experimental II 
                                                                                                                  N= 60 
Level of                 Experimental group I 
             mucositis 
Experimental group II 
                               7
th
 day                                          14
th 
day          7
th
 day           14
th
 day       
                                F        %             F          %                      F           %             F          % 
Ulceration 
No ulcer                   -         -             10       33.33                      -           -               5       
16.66             
Mild                        22     73.33        18          60                       21       70             19       
63.33 
Moderate                 8      26.66          2         6.66                      9         30             6          20   
Erythema 
No erythema            4     13.33           8       26.66                       3       10             6           20  
Not severe               26    86.66          22      73                           27       90           24         80 
 
           Data on table -5 shows that in experimental group I  22(73.33%) client had 
mild ulceration and 8(26.66%) client had moderate ulceration on 7
th
 day, on 14
th
 day 
10(33.33%) client had no ulceration and 18(60%) client had mild ulceration and 
2(6.66%)  client had moderate ulceration. Where as in the experimental group II on 
7
th
 day 21(70%) client had mild ulceration and 9(30%) client had moderate ulceration. 
On 14
th
 day 5(16.66%)  client had no ulceration and 19 (63.33)  client had no  
ulceration and  6(20%) client had  moderate ulceration. 
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         On 7
th
 day 4(13.33%) clients had no erythema and 26(86.66%) clients had not 
severe erythema . on 14
th
 day 8(26.66%) clients had no erythema and 22(73%) clients 
had not severe  erythema. Where as in the experimental group II on 7
th
 day 3(10%) 
clients had no erythema and 27 (90%) clients had not severe erythema, on 14
th
 day 
6(20%) clients had no erythema and 24 (80%) clients had not severe erythema. 
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FIGURE 8 : Distribution of subjects according to the post test level of oral 
ulceration  in experimental  group- I and II 
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FIGURE 9 : Distribution of subjects according to the post test level of oral 
erythema in experimental  group- I and II 
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SECTION – III 
Comparison of povidone- iodine mouth rinsing in reducing oral mucositis 
TABLE 6: 
         Comparison of mean pre test and post level of oral mucositis -ulceration 
among patients receiving radiation therapy after the povidone- iodine mouth 
rinsing in experimental group – I on 14th day  
          N =30 
Measurement                    N                     Mean                         SD                      t = value 
Pre test                                30                     11.06                         2.81                     
Post test                              30                       4.03                         3.33                     18.5* 
 
*Significant at  0.05 level. 
              To find out if there is any difference between the mean level of oral 
ulceration before and after use of povidone iodine mouth rinsing, the null hypothesis 
was stated as follows 
 H1: 
           The mean post test oral mucositis score in experimental group I who received 
povidone- iodine will not be significantly lower than their mean pre test oral 
mucositis score. In the present study mucositis status was measured by OMAS scale. 
A higher score indicates increased oral mucositis status where the lower score 
indicates decreased oral mucositis status. 
           Data on table -6 shows that  the mean  post test  level of povidone- iodine 
mouth rinsing (4.03) was lower than the pre test mean (11.06). The obtained ‘t’ value 
of (2.042) was significant at 0.05 level. This indicates that the difference has not 
occurred by chance. So the researcher rejects the null hypothesis and accepts the 
research hypothesis. 
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FIGURE 10:  Comparison of mean pre test and post level of oral ulceration 
among patients receiving radiation therapy after the povidone- iodine mouth 
rinsing in experimental group – I on 14th day 
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TABLE 7: 
         Comparison of mean pre test and post level of oral mucositis - erythema 
among patients receiving radiation therapy after the povidone- iodine mouth 
rinsing in experimental – I on 14th day 
                                                                                                                       N =30 
Measurement                    N                     Mean                         SD                      t = value 
Pre test                                30                     6.6                           1.85 
Post test                              30                      1.33                         0.94                       25.05* 
 
 *Significant at  0.05 level. 
 
 To find out if there is any difference between the mean level of oral erythema  
before and after use of povidone iodine mouth rinsing the null hypothesis was stated 
as follows 
H1: 
           The mean post test level of oral erythema  in experimental group I who 
received povidone iodine will not be significantly lower than their mean pre test oral  
erythema level. 
          Data on table -7 shows that  the mean post test level of povidone- iodine mouth 
rinsing  of the experimental group I(1.33) was lower than the pre test mean oral 
erythema level  (6.6). The obtained ‘t’ value of 25.05 (P =2.042) was significant at 
0.05 level. This indicates that the difference has not occurred by chance. So the 
researcher rejects the null hypothesis and accepts the research hypothesis. 
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FIGURE 11:  Comparison of mean pre test and post level of oral erythema 
among patients receiving radiation therapy after the povidone- iodine mouth 
rinsing in experimental – I on 14th day 
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TABLE 8: 
         Comparison of mean pre test and post level of oral mucositis- ulceration 
among patients receiving radiation therapy after the normal saline mouth 
rinsing in experimental - II on 14
th
 day 
                                                                                                                    N = 30 
Measurement                    N                     Mean                         SD                      t = value 
Pre test                                30                     10.23                        3.71                        
Post test                              30                       4.8                           3.52                     23.58* 
 
 *Significant at  0.05 level. 
              To find out if there is any difference between the mean level of  oral 
ulceration  before and after use of  normal saline mouth rinsing the null hypothesis 
was stated as follows 
H2: 
           The mean post test level of  oral ulceration  in experimental group II who 
received normal saline will not be significantly lower than their mean post test oral  
erythema level. 
          Data on table -8 shows that  the mean post test oral mucositis level of normal 
saline mouth rinsing sample  of the experimental group II(4.8) was lower than the pre 
test mean oral mucositis score (10.23). The obtained ‘t’ value of  23.58 at df 29 was 
significant at 0.05 level. This indicates that the difference has not occurred by chance. 
So the researcher rejects the null hypothesis and accepts the research hypothesis. 
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FIGURE 12: Comparison of mean pre test and post level of oral ulceration 
among patients receiving radiation therapy after the normal saline mouth 
rinsing in experimental - II on 14
th
 day 
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TABLE 9: 
         Comparison of mean pre test and post level of oral mucositis- erythema 
among patients receiving radiation therapy after the normal saline mouth 
rinsing in experimental - II on 14
th
 day 
                                                                                                                         N = 30 
Measurement                    N                     Mean                         SD                      t = value 
Pre test                                30                      6.7                           1.18                         
Post test                              30                      1.3                             0.9                        33.31*         
 
 *Significant at  0.05 level. 
              To find out if there is any difference between the mean level of oral eryhtema  
before and after use of  normal saline mouth rinsing the null hypothesis was stated as 
follows 
 
H2: 
           The mean post test level erythema in experimental group II who received 
normal saline will not be significantly lower than their mean post test  oral erythema 
level. 
          Data on table -9 shows that  the mean post test oral  mucositis level of normal 
saline mouth sample rinsing  of the experimental group II(1.3) was lower than the 
mean pre test oral mucositis score (6.7). The obtained‘t’ value of 33.31 at df 29 was 
significant at 0.05 level. This indicates that the difference has not occurred by chance. 
So the researcher rejects the null hypothesis and accepts the research hypothesis. 
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FIGURE 13: Comparison of mean pre test and post level of oral erythema 
among patients receiving radiation therapy after the normal saline mouth 
rinsing in experimental - II on 14
th
 day 
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TABLE 10: 
  Comparison of oral mucositis scores within the group of pre test - post test 1 
and post test 2 by repeated measures of  ANOVA method 
Test 
Experimental group I Experimental group II 
Ulceration Erythema Ulceration Erythema 
Mean SD 
F- 
value 
Mean SD 
F- 
value 
Mean SD 
F-
value 
Mean SD 
F- 
value 
Pre test 11.06 2.81  
 
40.15* 
6.6 1.85  
97.45* 
10.5 2.66  
23.03* 
6.7 1.18  
185.61* Post test 1 
(7
th
 day) 
7.56 2.83 3 1.45 7.16 3.40 3.23 1.15 
Post test 2 
(14
th
 day) 
4.03 3.33 1.33 0.94 4.8 3.52 1.3 0.9 
 
               The table 13 shows that the mean oral score in pre test (11.06) and after 
giving intervention the post test 1 value is (7.56) and post test 2 value is (4.03) in 
experimental group I. ulceration score and the obtained ‘F’ value is (40.15) is 
statistically significant at P < 0.001 level ,Regarding erythema score mean in pre test 
(6.6) and after giving intervention post test 1 value is (3) and post test 2 value is 
(1.33) and the obtained ‘F’ value is (97.45) is statistically significant at P < 0.001 
level .So, the intervention is  effective in reducing the level of oral  mucositis among 
patient receiving external therapy.  
            In experimental group II the ulceration score mean  in pre test (10.5) and after 
giving intervention post test 1 value is (7.16) and post test 2 value is (4.8)  and the 
obtained ‘F’ value is (23.03) is statistically significant at P < 0.001 level, In view to 
erythema mean score  in pre test (6.7) and after giving intervention post test 1 value is 
(3.23) and post test 2 value is (1.3) and the obtained ‘F’ value is (185.61) is 
statistically significant at P < 0.001 level .So, the intervention is reducing the oral 
mucositis symptoms effectively. 
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FIGURE 14: Comparison of with the group Pretest, Post test 1 and 
Post test 2 oral mucositis scores by repeated measures of ANOVA 
method. 
69 
TABLE 11: 
         Comparison of mean post test oral mucositis among  the experimental – I 
and  experimental - II  after povidone- iodone  and  normal saline mouth rinse on 
14
th
 day 
                                                                                                                              N = 30 
Group                           N               Mean                SD              t - value             P -Value 
Ulceration 
Experimental I              30               4.03                  3.33                18.5                   2.05* 
Experimental II            30                 4.8                   3.52                23.58                 2.05* 
Erythema  
Experimental I             30                 1.33                  0.94               25.04                 2.05* 
Experimental II           30                   1.3                   0.9                 33.31                 2.05* 
 
 *Significant at  0.05 level. 
              To find out if there is any difference between the mean level oral mocositis  
of experimental group I and experimental group II  after povidone- iodine and   
normal saline mouth rinse, the null hypothesis was stated as follows 
 
H3: 
           The mean post test oral  mucositis score of subject’s received povidone- iodine 
mouth rinse  will not be higher than the mean post test level of oral mucositis of 
patient received normal saline mouth rinse. 
          Data on table -10 shows the post test mean oral  mucositis score of 
experimental group I (4.03) after povidone- iodine  mouth rinse is significantly lower 
than the experimental group II(4.8)who received normal saline mouth rinse. The 
obtained ‘t’ value of (P = 2.05) was  significant at 0.05 level. This difference between 
70 
the mean (0.77) is a true difference, and has not occurred by chance. It can be inferred 
that povidone -iodine mouth rinse has significant role in reducing oral  mucositis 
level. So the researcher reject null hypothesis and accept the research hypothesis. The 
mean post test erythema score of experimental group I(1.33) is significantly higher 
than the experimental group II(1.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
71 
 
 
4.03
3.33
4.8
3.52
0
1
2
3
4
5
6
M
e
a
n
Experimental
Group I
Experimental
Group II
Mean
SD
 
FIGURE 15: Comparison of mean post test oral mucositis among  the 
experimental – I and  experimental - II  after povidone- iodine  and  normal 
saline mouth rinse on 14
th
 day 
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TABLE 12: 
  Comparison between groups of pre test, post test 1 and post test 2 oral 
mucositis score by repeated measures of ANOVA method 
 
         The table 12 shows that the mean oral ulceration of score experimental group I 
and II, on 7
th
 day was found statistically significant with the ‘F’ value of 
13.44(P<0.001), whereas on 14
th
 day the mean oral ulceration score was found 
statistically significant with the ‘F’ value of 41.39(P<0.001). 
         Regarding the mean oral erythema score of experimental group I and II, on 7
th
 
day was found statistically significant with the ‘F’ value of 59.57(P<0.001), likewise 
on 14
th
 day the mean oral erythema score was found statistically significant with the 
‘F’ value of 167.35(P<0.001). 
        This denotes the healing pattern is different in both group in consequent days. 
The healing was faster in experimental group I when compared to experimental group 
II, and 7
th
 day itself. This change was statistically seen. 
                                                           
Test 
Ulceration Erythema 
Mean SD F- value  P- value Mean SD 
F-
value 
P- 
value 
Pre test 
(Exp.group I) 
11.06 2.81  
  
  6.6 1.85  
 
 
 
Pre test 2 
( Exp.groupII) 
10.5 2.66 6.7 1.18 
Post test 1 
(E.G-I,7
th
 day) 
7.56 2.83  
13.44 
  
6.85* 
3 1.45  
59.57 
  
   
6.85* Post test 1 
(E.G-II,7
th
 day) I) 
7.16 3.40 3.23 1.15 
Post test 2 
(E.G- I,14
th
 day) 
4.03 3.33  
41.39 
  
6.85* 
1.33 0.94  
167.35 
   
    
6.85* Post test 2 
(E.G- II,14
th
 day) 
4.8 3.52 1.3 0.9 
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SECTION – IV 
     This  section  deal with the association between pre test oral  mucositis level of 
experimental group I  select demographic variables Age, Sex, Education, Occupation, 
Marital status, History of smoking, History of betel chewing, History of  pan/ kutka. 
 
TABLE 13: 
          Association  between the levels of oral mucositis of the experimental group 
I before the use of povidone-iodine mouth rinsing with demographic variables. 
 
Variables 
Level of ulceration 
Above 
mean 
Below 
mean 
Df 
chi 
square 
P value 
Age( in year): 
29 – 38 year 
39 – 48 year 
49 – 58 year 
 
5 
5 
6 
 
1 
9 
4 
3 2.81 7.82# 
Sex:   
   Male                               
   Female                            
 
13 
3 
 
10 
4 
1 0.13 3.84# 
Education status: 
Illterature                         
   Literature                         
 
8 
8 
 
6 
8 
1 0.41 3.84# 
Occupation: 
  Sedentary  worker             
  Moderate  worker              
 
8 
8 
 
11 
3 
 
1 
 
0.32 
 
3.84# 
Marital status: 
  Single                                 
  Married                            
 Unmarried                          
 Widow                               
- 
15 
- 
11 
- 
13 
- 
1 
3 0.24 7.82# 
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Variables 
Level of ulceration 
Above 
mean 
Below 
mean 
Df 
chi 
square 
P value 
H/o smoking: 
 Yes                                     
 No                                       
 
11 
5 
 
8 
6 
1 1.13 3.84# 
H/o betel chewing:   
 Yes                                      
 No                                        
 
7 
8 
 
6 
9 
 
1 
 
1.06 
 
3.84# 
H/o pan/ kutka: 
Yes                                        
 No                                        
 
1 
15 
 
0 
14 
 
1 
 
0.94 
 
3.84# 
 
*Significant at  0.05 level 
# not Significant at  0.05 level 
 
                  To find out if there is any association between oral mucositis score of the 
subjects and  the selected or demographic and clinical variables of  samples such as 
age, sex, education, occupation, marital status, history of smoking, history of betel nut 
chewing, history of pan/  kutka chewing, the null hypothesis was selected as follows 
H4: 
           There will be no significant association between the experimental group I oral 
mucositis score and demographic and clinical variables such as age, sex, education, 
occupation, marital status, history of smoking, history of betel nut chewing, history of 
pan/  kutka chewing. 
 In order to find out the association between the mucositis score and age the 
chi-quare test was computed. The obtained chi-quare  value of  2.81 was not 
significant at 0.05 level (df -3) 
 Regarding oral mucositis score and sex the calculated value 0.13 at (df -1) was 
not  significant at 0.05 level. 
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 Regarding oral mucositis score and education status the calculated value 0.41 
at (df -1) was not  significant at 0.05 level. 
 Regarding oral mucositis scale and sex the calculated value 0.13 at (df -1) was 
not  significant at 0.05 level. 
 Regarding oral mucositis score and occupation the calculated value 0.32 at (df 
-1) was not  significant at 0.05 level. 
 Regarding oral mucositis score and marital status the calculated value 0.24 at 
(df -1) was not  significant at 0.05 level. 
 It was found that there was no association between history of smoking, betel, 
pan/ kutka chewing. The chi- square  value 1.13 and 1.06 and 0.94 (df -1)  was 
not significant at 0.05 level. 
        There is no significant association between the pre test oral mucositis score and 
selected demographic variables such as age, sex, education, occupation, marital status, 
history of smoking, history of betel nut chewing, history of pan/  kutka chewing. 
        So the researcher accepts the null hypothesis, and reject the research hypothesis. 
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  TABLE 14: 
          Association  between the levels of oral mucositis of the experimental group 
II before the use of normal saline mouth rinsing with demographic variables. 
 
Variables 
Level of ulceration 
Above 
mean 
Below 
mean 
Df 
chi 
square 
P value 
Age( in year): 
29 – 38 year 
39 – 48 year 
49 – 58 year 
 
3 
6 
3 
1 
9 
8 
3 86.8 7.82* 
Sex:   
   Male                               
   Female                            
8 
4 
9 
9 
1 1.2 3.84# 
Education status: 
Illterature                         
   Literature                         
6 
6 
6 
12 
1 0.06 3.84# 
Occupation: 
  Sedentary  worker             
  Moderate  worker              
9 
2 
13 
6 
1 0.97 3.84# 
Marital status: 
  Single                                 
  Married                            
 Unmarried                          
 Widow                               
- 
12 
- 
0 
- 
16 
- 
2 
3 3.32 7.82# 
H/o smoking: 
 Yes                                     
 No                                       
 
4 
8 
 
8 
10 
1 1.81 3.84# 
 
(Table continued ….) 
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Variables 
Level of ulceration 
Above 
mean 
Below 
mean 
Df 
chi 
square 
P value 
H/o betel chewing:   
 Yes                                      
 No                                        
6 
6 
8 
10 
1 0.52 3.84# 
H/o pan/ kutka: 
Yes                                        
 No                                        
 
0 
0 
 
1 
17 
 
1 
 
1.02 
 
3.84# 
 
*Significant at  0.05 level 
# not Significant at  0.05 level 
 
      To find out if there is any association between oral mucositis score of the subjects 
and the selected  demographic and clinical variables of  such as age, sex, education, 
occupation, marital status, history of smoking, history of betel nut chewing, history of 
pan/  kutka chewing, the null hypothesis was selected as follows 
 
H5: 
         There will be no significant association between the experimental groupI I oral 
mucositis score and demographic and clinical variables of such as age, sex, education, 
occupation, marital status, history of smoking, history of betel nut chewing, history of 
pan/  kutka chewing. 
 Regarding oral mucositis score and age the calculated value 86.8 at (df -1) was   
significant at 0.05 level. 
 Regarding oral mucositis score and sex the calculated value 1.2 at (df -1) was 
not significant at 0.05 level. 
 Regarding oral mucositis score and education status the calculated value 0.06 
at (df -1) was not significant at 0.05 level. 
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 Regarding oral mucositis scale and ocupation the calculated value 0.97 at (df -
1) was not  significant at 0.05 level. 
 Regarding oral mucositis score and marital status the calculated value 3.32 at 
(df -1) was not  significant at 0.05 level. 
 It was found that there was no association between history of smoking, betel, 
pan/ kutka chewing. The chi- square  value 1.81 and 0.52 and 1.02 (df-1) 
 
 There is no significant association between the pre test oral mucositis score and 
selected demographic variables such as  Sex, Education, Occupation, Marital status, 
History of smoking, History of betel nut chewing, History of pan/  kutka chewing. 
Since the association was found only between the pre test oral mucositis score 
and age  (2 =86.8) after administration of normal saline mouth rinse, the researcher is 
unable to reject the null hypothesis and hence accept the research hypothesis. 
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CHAPTER -V 
DISCUSSION 
 
        A study to assess the effectiveness of povidone- iodine Vs normal saline mouth 
rinsing on oral mucositis among patient with head and neck malignancies who is 
receiving radiation therapy from selected hospital in Madurai. This study was 
conducted among patients with head and neck cancer who receiving radiation therapy. 
The tool used for study was oral mucositis assessment scale (OMAS) 
 
MAJOR FINDINGS OF THE STUDY 
DEMOGRAPHIC VARIABLES OF SAMPLES: 
 Regarding the age most of the sample 14(46.66%) were between the age of 
39-48 years in experimental group I and 15(50%) belongs to 39-48 years in 
experimental group II. 
 Regarding sex in both experimental group I and II majority of the samples 
were male 23(76.66%) and 17 (56.66%) respectively. 
 Regarding education status both experimental group I and II most of them are 
literate 16 (53.33%) and 18 (60%) respectively. 
 Regarding occupation majority of the samples are sedentary workers in both 
experimental group I  19 (63.33%)and in experimental group II   22(73.33%). 
 Regarding marital status most of them are married in experimental group I  
28(93.33%) and in the experimental group II 27(90%) respectively. 
 With regards to smoking history most of them had the habits of smoking in 
experimental group I 19(63.33%) and in experimental group II   12(40%) 
respectively. 
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CLINICAL PROFILE: 
 The  majority of the sample had cancer larynx, 13(43.33%) in experimental group 
I and  experimental group II 14(46.66%). 
  Regarding severity of the tumor in both experimental group I and II majority of 
the samples had tumor size ranging from( Tx – T4b),  20(66.66%)  and 19 
(63.33%). 
  Regarding  dose of radiation therapy administered to the all the sample 30(100%) 
were similar in the dose of  200c Gy  in both experimental group I and II.  
   
          The present study finding is similar to study findings of  Saldanha  and 
Almeida  (2014),described that  majority of the subjects 18 (90%) in group I and 16 
(80%) in group II had cancer of head and neck, whereas 2 (10%) in group I and 4 
(20%) in group II had cancer of other origin. The study findings are in accordance 
with the findings of a study conducted in USA to characterize the risks and clinical 
consequences of oral mucositis (OM) in patients with Head and Neck Carcinoma 
(HNC) which showed that primary tumor locations included the oropharynx (26.4%), 
larynx (26.4%), oral cavity including the lip (24.4%), hypo pharynx (13.6%), and 
nasopharynx (9.1%). 
 
1.The first objects is to  explore  the severity of oral mucositis  before and after 
providing  povidone –iodine(2%) and normal saline(0.9%) rinses among  
patients receiving external radiation therapy  for head and neck malignancies. 
           As per the Table – 3 shows that before using of povidone- iodine mouth rinsing 
there was 10(33.33%) clients had mild ulceration and 20(66.66%) clients had 
moderate ulceration. After povidone iodine mouth rinsing, on 7
th
 day 22(73.33%) 
clients had mild ulceration and 8(26.66%) clients had moderate ulceration, on 14
th
 day 
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10(33.33%) clients had no ulcer, 18(60%) clients had mild ulceration and 2(6.66%) 
clients had moderate ulceration. For erythema non of them had no erythema, 
30(100%) sample had not severe erythema during prê test. After using of povidone- 
iodine mouth rinsing, on 7
th
 day 4(13.33%) clients had no erythema, 26(76.66%) 
clients had not severe  erythema, on 14
th
 day  8(26.66%) clients had no erythema, 
22(73.33%) had not severe  erythema. This difference may be due to effect of 
povidone- iodine mouth rinsing. 
As per the Table – 4 shows that before using of normal saline mouth rinsing 
there was 15(50%) samples had mild ulceration and 15(50%) samples had moderate 
ulceration . After  using  of normal saline mouth rinsing, on 7
th
 day 21(70%) samples 
had mild ulceration  and 9(30%) samples had moderate ulceration, on 14
th
 day 
5(16.66%) clients had no ulceration  and 19(63.33%) samples had mild ulceration  
and 6(20%) samples had moderate ulceration. This is due to the effect of normal 
saline mouth rinsing. For erythema during pretest 30(100%) samples had not severe  
erythema, on 7
th
 day 3(10%) samples had no erythema and 27(90%) samples had not 
severe  erythema, on 14
th
 day 6(20%) samples had no erythema and 24 (80%) samples 
had not severe  erythema. 
          The present study findings is similar to findings of   Elting , Cooksley and  
Chambers(2007), they have explained that Patients treated with radiation therapy for 
head and neck cancer typically receive an approximately 200 cGy daily dose of 
radiation, five days per week, for 5–7 continuous weeks. Almost all such patients 
developed some degree of oral mucositis, severe oral mucositis occurred in 29(66% 
)of all patients receiving radiation therapy for head and neck cancer. The incidence of 
oral mucositis was especially high in 1) patients with primary tumors in the oral 
cavity, oropharynx or nasopharynx, 2) those who also received concomitant 
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chemotherapy, 3) those who received a total dose over 5000 cGy, and 4) those who 
were treated with altered fractionation radiation schedules (e.g. more than one 
radiation treatment per day). 
 
2.To find out the  effectiveness of povidone –iodine(2%)  mouth rinsing on oral 
mucosititis among the patients with  head and neck malignancies in experimental 
group I. 
       As per the table -6 shows that the mean post test level of povidone iodine mouth 
rinsing (4.03) was lower than the pre test ulceration mean (11.06). The obtained ‘t’ 
value of 18.5 (P=2.042) was significant at 0.05 level.  As per the table -7 shows that  
the mean post test level of povidone iodine mouth rinsing  of the experimental group 
I(1.33) was lower than the pre test erythema  mean (6.6). The obtained ‘t’ value of 
25.05 (2.042) was significant at 0.05 level. This indicates that the difference between 
the mean was (7.03) was a true difference. The difference between the mean could be 
due to the effect of povidone iodine. 
The present study finding is similar to study findings of  Fleischer (2007) 
A prospective randomized controlled trial was conducted to assess the efficiency of 
povidone iodine mouthwash on radio and chemotherapy treatment with 40 patients 
undergoing radiation or chemotherapy in head and neck region. Twenty patients 
rinsed povdone iodine mouthwash four times daily while other group for comparison 
rinsed with sterile water. Clinical examination of oral mucositis was done weekly. In 
povidone iodine group the mean oral mucositis grade was 1 and in the comparison 
group mean oral mucositis grade was 3. The study also showed that duration of 
healing of oral mucositis in povidone iodine group was 2.75 weeks and in the control 
group it was 9.25 weeks. This showed that the incidence, severity and duration of 
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radiotherapy and chemotherapy induced oral mucositis can be significantly reduced 
by oral rinsing with povidone iodine mouthwash. 
 
3.To find out the  effectiveness of normal saline (0.9%) mouth rinsing  on oral 
mucosititis among patient with  head and neck malignancies in experimental 
group II 
        As per the table -8 shows that the mean post test oral mucositis level of normal 
saline mouth rinsing sample of the experimental group II(4.8) was lower than the pre 
test mean (10.23). The obtained ‘t’ value of  23.58 at df 29 was significant at 0.05 
level. As per the table -9 shows that  the mean post test level mucositis score of 
normal saline mouth rinsing  sample of the experimental group II(1.3) was lower than 
the mean pre test mucositis score  (6.7). The obtained ‘t’ value of  33.31 at df 29 was 
significant at 0.05 level. This indicates that the difference between the mean was 
(5.43) was a true difference. The difference between the mean could be due to the 
effect of normal saline. 
 The present study finding is similar to study findings of  Yoneda, Imai 
and Hanada, et al.,(2008) stated that  The MASCC/ISOO guidelines recommend use 
of a standardized oral care protocol including brushing with a soft toothbrush, flossing 
and the use of non-medicated rinses (e.g. saline or sodium bicarbonate rinses). 
Patients and caregivers should be educated regarding the importance of effective oral 
hygiene. Alcohol-containing chlorhexidine mouth rinse may be difficult for patients 
to tolerate during clinical oral ulceration, thus formulations without alcohol are used 
at some centers. Multiple studies have examined the role of chlorhexidine mouth rinse 
in oral mucositis but have not demonstrated significant efficacy in reducing severity 
of mucositis. Therefore, the MASCC/ISOO guidelines recommend against the use of 
chlorhexidine mouth rinse for prevention or treatment of oral mucositis. 
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           Wuketich and Hienz (2002) described that the mainstay of an effective oral 
care regimen is mouth rinses, and just plain salt water is one of the best and most cost 
effective mouth rinses available. A mouth rinse aides in removing debris and keeping 
the oral tissue moist and clean. Good oral care, defined as frequently rinsing the 
mouth with saline, may help prevent mouth sores Salt mouthwash can soothe the pain 
and keep food particles clear so as to avoid infection. Normal saline (0.9%) is a not 
irritant and is believed to help in formation of granulation tissue and to promote 
healing. Its safe, economical and readily available mouthwash, the use of which can 
be promoted. 
 
4.To compare the post test level of oral mucositis  score between experimental 
group I and  II. 
Data on table -11 shows the post test mean mucositis score of experimental 
group I (4.03) after povidone iodine  mouth rinse is significantly lower than the 
experimental group II(4.8)who received normal saline mouth rinse. The obtained ‘t’ 
value of (P = 2.05) was  significant at 0.05 level. This difference between the mean 
(0.77) is a true difference, and has not occurred by chance. It can be inferred that 
povidone iodine mouth rinse has significant role in reducing mucositis level. So the 
researcher reject null hypothesis and accept the research hypothesis. The mean post 
test erythema score of experimental group I (1.33) is significantly higher than the 
experimental group II(1.3). 
             The table 12 shows that the mean oral ulceration of score experimental group 
I and II, on 7
th
 day was found statistically significant with the ‘F’ value of 13.44 
(P<0.001), whereas on 14
th
 day the mean oral ulceration score was found statistically 
significant with the ‘F’ value of 41.39(P<0.001). 
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           Regarding the mean oral erythema score of experimental group I and II, on 7
th
 
day was found statistically significant with the ‘F’ value of 59.57(P<0.001), likewise 
on 14
th
 day the mean oral erythema score was found statistically significant with the 
‘F’ value of 167.35(P<0.001).  This denotes the healing pattern is different in both 
group in consequent days. The healing was faster in experimental group I when 
compared to experimental group II, and 7
th
 day itself. This change was statistically 
seen. 
The present study finding is similar to study findings of Potting (2006), He 
conducted a study of  effectiveness of commonly used mouthwashes for the 
prevention and treatment of chemotherapy-induced oral mucositis. A systemic review 
was conducted to assess the effectiveness of mouthwashes in preventing and treating 
chemotherapy-induced oral mucositis. Based on study quality, three out of five 
randomized controlled trials were included in a meta-analysis. The results failed to 
detect any beneficial effects of chlorhexidine as compared with sterile water, or NaCl 
0.9%. The severity of oral mucositis was shown to be reduced by 30% using a 
povidone-iodine mouthwash as compared with sterile water in a single randomized 
controlled trial. These results do not support the use of chlorhexidine mouthwash to 
prevent and treat oral mucositis.  
 
 5.To determine  the association between pre test  level of oral mucosititis score of  
experimental group I with selected demographical variables (i.e. Age, sex, 
occupation, marital status, education status, smoking ,tobacco chewing, betel 
nuts and pan or kutka chewing). 
 As per table – 13 findings, there is no significant association between the pre 
test mucositis score of experimental group I and selected demographic variables such 
as Age, Sex, Education, Occupation, Marital status, History of smoking, History of 
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betel nut chewing, History of pan/  kutka chewing. So the researcher accepts the null 
hypothesis, and rejects the research hypothesis. 
 
6.To determine  the association between pre test level of oral mucosititis score of  
experimental group II with selected  demographical variables(i.e. Age, sex, 
occupation, marital status, education status, smoking, tobacco chewing, betel 
nuts and pan or kutka chewing). 
 As per the table -14 findings, Regarding mucositis score and age the 
calculated value 86.8 at (df -1) was  significant at 0.05 level. 
 There is no significant association between the pre test mucositis score and 
selected demographic variables such as  Sex, Education, Occupation, Marital 
status, History of smoking, History of betel nut chewing, History of pan/  
kutka chewing 
 
 The present study finding is similar to study findings of, Mountzios (2015)  
stated that head and neck cancer (HNC) represents the sixth most common 
malignancy and accounts for approximately 6% of new cancer cases annually 
worldwide. As life expectancy constantly increases, the onset of head neck cancer in 
patients older than 65 years of age at diagnosis is not rare and up to one fourth of 
cases occurs in patients older than 70 years at age. Because elderly cancer patients are 
severely under-represented in clinical trials, there is a clear need to address the 
particular aspects of this specific patient group, especially in the context of novel 
multidisciplinary therapeutic approaches. The frailty of elderly patients with head 
neck cancer is attributed to the high incidence of smoking and alcohol abuse in this 
malignancy and the presence of substantial cardiovascular, respiratory or metabolic co 
morbidities.  
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CHAPTER  -VI 
SUMMARY, CONCLUSION, IMPLICATIONS AND 
RECOMMENDATIONS 
 
        This chapter deals with the summary, conclusion and implications of the study in 
the field of nursing. It also presents the recommendations for the future research. 
 
SUMMARY OF THE STUDY: 
 “ A  study to assess the effectiveness of   povidone –iodine (2%) vs normal 
saline(0.9%) mouth rinsing on oral mucositis among patients receiving external 
radiation therapy for head and neck malignancy  from Devaki Cancer and  Research 
Centre  at Madurai”. 
The following objectives were set for the study, 
 To  explore  the severity of oral mucositis  before and after providing  
povidone –iodine(2%) and normal saline(0.9%) rinses among  patients 
receiving external radiation therapy  for head and neck malignancies. 
 To find out the  effectiveness of povidone –iodine(2%)  mouth rinsing on oral 
mucosititis among the patients with  head and neck malignancies in 
experimental group I 
 To find out the  effectiveness of normal saline (0.9%) mouth rinsing  on oral 
mucosititis among patient with  head and neck malignancies in experimental 
group II 
 To compare the post test level of oral mucositis  score between experimental 
group I and  II  
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 To determine  the association between pre test  level of oral mucosititis score 
of  experimental group I with selected demographical variables (i.e (Age, sex, 
occupation, marital status, education status, smoking ,tobacco chewing, betel 
nuts and pan or kutka chewing) 
 To determine the association between pre test level of oral mucosititis score of 
experimental group II with selected  demographical variables (i.e (Age, sex, 
occupation, marital status, education status, smoking ,tobacco chewing, betel 
nuts and pan or kutka chewing). 
 
HYPOTHESES: 
H1: 
             The mean post test oral mucositis score of patient with oral mucositis who 
receives povidone –iodine (2%) mouth rinse will be significantly lower than the mean 
pretest  oral mucositis score of patient in  experimental group I. 
 H2: 
           The mean post test oral mucositis score of patient with oral mucositis who 
received normal saline (0.9%)  will be significantly lower than mean pretest oral 
mucositis score of patient in  experimental  group II. 
 
 H3: 
          There will be a significant difference between the mean post test level of oral 
mucositis score of experimental group I who received the povidone –iodine (2%) and 
experimental group II who received the normal saline (0.9%)  mouth rinse. 
       
 H4: 
         There will be significant association between  pretest  oral mucositis score, 
among patient who received  povidone –iodine (2%)   mouth rinse with selected 
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variables(Age, sex, occupation, marital status, education status, smoking ,tobacco 
chewing, pan ,betel nuts chewing). 
      
H5: 
         There will be a significant association between the post test  oral mucositis  
score among patient who received normal saline (0.9%)    rinse with selected 
variables(Age, sex, occupation, marital status, education status, smoking ,tobacco 
chewing, pan ,betel nuts chewing). 
               An experimental approach was used for the study. The design adopted was 
quasi experimental pre test – post test design with two experimental groups. The study 
was conducted in Devaki Cancer and  Research Centre, Madurai which is 7.6km away 
from the Sacred  Heart Nursing College, Madurai. Simple random sampling was used 
to select the samples. A total 60 samples were selected and among that 30 samples 
were treated with povidone – iodine and remaining 30 samples were treated with 
normal saline. Oral mucositis assessment scale was used for data collection. Data 
collection procedure was done for six weeks. After data collection, data was 
organized, tabulated, summarized and analyzed. 
 
MAJOR FINDINGS OF THE STUDY: 
I.  Demographic characteristics of the samples: 
 Regarding the age, most of the sample 14(46.66%) were between the age of 
39-48 years in experimental group I and 15(50%) belongs to 39-48 years in 
experimental group II. 
 Regarding sex in both experimental group I and II majority of the samples 
were male 23(76.66%) and 17 (56.66%) respectively. 
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 Regarding education status both experimental group I and II most of them are 
literate 16 (53.33%) and 18 (60%) respectively. 
 Regarding occupation majority of the samples are sedentary workers in both 
experimental group I 19 (63.33%) and in experimental group II   22(73.33%). 
 Regarding marital status most of them are married in experimental group I 
28(93.33%) and in the experimental group II 27(90%) respectively. 
 With regards to smoking history most of them had the habits of smoking in 
experimental group I 19(63.33%) and in experimental group II   12(40%) 
respectively. 
 
II. Clinical profile: 
 The majority of the sample had cancer larynx, 13(43.33%) in experimental 
group I and experimental group II 14(46.66%). 
  Regarding severity of the tumor in both experimental group I and II majority 
of the samples had tumor size ranging from (Tx – T4b), 20(66.66%) and 19 
(63.33%)  
  Regarding the dose of radiation administered per day for all the 
samples(100%)in both experimental group I and II were similar in receiving 
dose of 200 cGy per day.    
 The above data shows that experimental group I and group II were similar in 
the form of demographic variables such as age, sex, education status, 
occupation, marital status, history of smoking, location of the tumor, severity 
of tumor, dose of radiation therapy. 
 
III. Distribution of participants according to level of mucositis healing in 
experimental group – I showed that 10(33.33%) clients had mild ulceration and 
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20(66.66%) clients had moderate ulceration. After povidone- iodine mouth rinsing, on 
7
th
 day 22(73.33%) clients had mild ulceration and 8(26.66%) clients had moderate 
ulceration, on 14
th
 day 10(33.33%) clients had no ulcer, 18(60%) clients had mild 
ulceration and 2(6.66%) clients had moderate ulceration. For erythema 8(26.66%) 
clients had mild erythema, 22(73.33%) had moderate erythema. After using of 
povidone iodine mouth rinsing, on 7
th
 day 4(13.33%) clients had no erythema, 
26(76.66%) clients had mild erythema. This difference may be due to effect of 
povidone- iodine mouth rinsing. 
 
IV. Distribution of participants according to level of mucositis healing in 
experimental group- II showed that 15(30%) samples had mild ulceration  and 
15(30%) samples had moderate ulceration . After  using  of normal saline mouth 
rinsing, on 7
th
 day 21(70%) samples had mild ulceration  and 9(30%) samples had 
moderate ulceration, on 14
th
 day 5(16.66%) clients had no ulceration  and 19(63.33%) 
samples had mild ulceration  and 6(20%) samples had moderate ulceration. This is 
due to the effect of normal saline mouth rinsing. For erythema during pretest 
30(100%) samples had mild erythema, on 7
th
 day 3(10%) samples had no erythema 
and 27(90%) samples had mid erythema, on 14
th
 day 6(20%) samples had no 
erythema and 24 (80%) samples had mid erythema. 
 
V. The mean post test level of povidone iodine mouth rinsing (4.03) was lower than 
the pre test mean (11.06). 
 
VI. The mean post test level of povidone iodine mouth rinsing of the experimental 
group I(1.33) was lower than the pre test mean (6.6). 
 
VII.The mean post test level of normal saline mouth rinsing of the experimental 
group II(4.8) was lower than the pre test mean (10.23). 
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VIII. The mean post test level of normal saline mouth rinsing of the experimental 
group II(1.3) was lower than the pre test mean (6.7). 
 
IX. The post test mean ulceration score of experimental group I (4.03) after povidone 
iodine mouth rinse is significantly lower than the experimental group II(4.8). 
 
X. The mean post test erythema score of experimental group I(1.33) is significantly 
higher than the experimental group II(1.3). 
 
XI. There was a significant association between the pre test mucositis score of  
experimental group II and age the calculated value (86.8) at   (df- 3) was significant at 
0.05 level. 
 
CONCLUSION: 
The following conclusions were drawn from the study, 
 The level of oral mucositis status of subjects after use of povidone – iodine was 
lower than the level of oral mucositis status before use of  povidone – iodine 
mouth rinse. 
 The  level of  oral mucositis status of subjects after use of normal saline  was 
lower than the level of oral  mucositis status before use of normal saline  mouth 
rinse. 
 The povidone – iodine mouth rinse was found effective in improving the oral 
mucositis status of patient with oral mucositis when compared  with normal saline 
mouth rinse. 
 There was no significant association between the pre test oral  mucositis score of 
experimental group I and selected demographical variables such as  a age, sex, 
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education status, occupation, marital status, history of smoking, betel chewing, 
pan or kutka. 
 There was a significant association between the pre test mucositis score of 
experimental group II and  age the calculated value  X2 - 86.8 at (df -3) was 
significant at o.o5 level. 
 
IMPLICATION: 
 The findings of the study have practical application. The study could be 
discussed in four areas namely nursing practice, nursing administration, nursing 
education and research. 
 
a) Implication for nursing practice: 
 Early identification and prevention of oral mucositis among patient with head 
and neck cancer is essential. 
 As povidone- iodone and normal saline is less expensive and have no adverse 
effects, nurse can use readily. 
 Nurse must assess the oral  cavity of the patients receiving radiation therapy by 
using oral mucositis assessment scale to measure the mucositis status and treat 
accordingly. 
 The study findings will help the nursing personal to includes these nursing 
interventions in the management of oral mucositis. 
 There should be a routine practice of  using povidone –iodine and normal saline 
mouth rinse among  patient who develops oral mucositis. 
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b) Implication for nursing education : 
 This study has clearly proved that povidone – iodine mouth rinse was more 
effective in treating the oral mucositis. 
 These findings would help the nursing faculty to give importance to use 
povidone – iodine mouth rinse in the management of oral mucositis and 
motivate the nursing student to use of this in the management of oral 
mucositis among whom undergoing cancer treatment. 
 Different type of oral mucositis scale can be used in the nursing 
curriculum. 
 
c) Implication for nursing research: 
 There is a need for extensive and intensive research in this area. One of 
thise aims of nursing research is to expand and broaden the scope of 
nursing. Findings of this study will provide base line data about the oral 
mucositis healing and it can be used for further studies in these area. 
 
d) Implication for nursing administration: 
 Nursing administration can encourage the nursing personnel to conduct 
research on oral mucositis among patient with cancer and give care 
based on findings. 
 Periodic conference, seminars and symposium can be arranged for 
nursing personnel regarding care of oral mucositis among patient with 
cancer therapy. 
 Education should be given to clinical nurses and educators to updates 
knowledge regarding management of oral mucositis among patient with 
cancer. 
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 Nursing administrator’s should prepare procedure manuals and protocols 
regarding administration of mouth rinsing and use them in the wards and 
ensure the availability. 
 
LIMITATIONS:  
 Because of the small sample size and setting selection, The findings must be 
interpreted with caution. 
 Intervention given only for 14 days. 
 
 
RECOMMENDATIONS OF THE STUDY: 
 The study can be conducted by using large population to generalize the findings. 
 A longitudinal study can be conducted to assess the effectiveness of selected 
nursing interventions on reducing radiation induced oral mucositis. 
 Effectiveness of various other mouth rinse on oral mucositis can be done as 
comparative study in different settings. 
 The effectiveness of mouth rinse can be tested for other type of oral mucositis. 
 Qualitative study can be conducted to identify the in-depth oral  ulcer problems 
experienced by the patients who are receiving  radiation therapy. 
 Incidence of oral mucositis level can be assessed among cancer patient. 
 The same study can be repeated using true experimental design. 
 The study can assess the pain level of oral mucositis among patients   with head 
and neck cancer receiving radiation therapy. 
 An explorative study can be done to find out the side effects of radiation therapy 
among patients with head and neck cancer. 
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CHAPTER  -VI 
SUMMARY, CONCLUSION, IMPLICATIONS AND 
RECOMMENDATIONS 
 
        This chapter deals with the summary, conclusion and implications of the study in 
the field of nursing. It also presents the recommendations for the future research. 
 
SUMMARY OF THE STUDY: 
 “ A  study to assess the effectiveness of   povidone –iodine (2%) vs normal 
saline(0.9%) mouth rinsing on oral mucositis among patients receiving external 
radiation therapy for head and neck malignancy  from Devaki Cancer and  Research 
Centre  at Madurai”. 
The following objectives were set for the study, 
 To  explore  the severity of oral mucositis  before and after providing  
povidone –iodine(2%) and normal saline(0.9%) rinses among  patients 
receiving external radiation therapy  for head and neck malignancies. 
 To find out the  effectiveness of povidone –iodine(2%)  mouth rinsing on oral 
mucosititis among the patients with  head and neck malignancies in 
experimental group I 
 To find out the  effectiveness of normal saline (0.9%) mouth rinsing  on oral 
mucosititis among patient with  head and neck malignancies in experimental 
group II 
 To compare the post test level of oral mucositis  score between experimental 
group I and  II  
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 To determine  the association between pre test  level of oral mucosititis score 
of  experimental group I with selected demographical variables (i.e (Age, sex, 
occupation, marital status, education status, smoking ,tobacco chewing, betel 
nuts and pan or kutka chewing) 
 To determine the association between pre test level of oral mucosititis score of 
experimental group II with selected  demographical variables (i.e (Age, sex, 
occupation, marital status, education status, smoking ,tobacco chewing, betel 
nuts and pan or kutka chewing). 
 
HYPOTHESES: 
H1: 
             The mean post test oral mucositis score of patient with oral mucositis who 
receives povidone –iodine (2%) mouth rinse will be significantly lower than the mean 
pretest  oral mucositis score of patient in  experimental group I. 
 H2: 
           The mean post test oral mucositis score of patient with oral mucositis who 
received normal saline (0.9%)  will be significantly lower than mean pretest oral 
mucositis score of patient in  experimental  group II. 
 
 H3: 
          There will be a significant difference between the mean post test level of oral 
mucositis score of experimental group I who received the povidone –iodine (2%) and 
experimental group II who received the normal saline (0.9%)  mouth rinse. 
       
 H4: 
         There will be significant association between  pretest  oral mucositis score, 
among patient who received  povidone –iodine (2%)   mouth rinse with selected 
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variables(Age, sex, occupation, marital status, education status, smoking ,tobacco 
chewing, pan ,betel nuts chewing). 
      
H5: 
         There will be a significant association between the post test  oral mucositis  
score among patient who received normal saline (0.9%)    rinse with selected 
variables(Age, sex, occupation, marital status, education status, smoking ,tobacco 
chewing, pan ,betel nuts chewing). 
               An experimental approach was used for the study. The design adopted was 
quasi experimental pre test – post test design with two experimental groups. The study 
was conducted in Devaki Cancer and  Research Centre, Madurai which is 7.6km away 
from the Sacred  Heart Nursing College, Madurai. Simple random sampling was used 
to select the samples. A total 60 samples were selected and among that 30 samples 
were treated with povidone – iodine and remaining 30 samples were treated with 
normal saline. Oral mucositis assessment scale was used for data collection. Data 
collection procedure was done for six weeks. After data collection, data was 
organized, tabulated, summarized and analyzed. 
 
MAJOR FINDINGS OF THE STUDY: 
I.  Demographic characteristics of the samples: 
 Regarding the age, most of the sample 14(46.66%) were between the age of 
39-48 years in experimental group I and 15(50%) belongs to 39-48 years in 
experimental group II. 
 Regarding sex in both experimental group I and II majority of the samples 
were male 23(76.66%) and 17 (56.66%) respectively. 
90 
 Regarding education status both experimental group I and II most of them are 
literate 16 (53.33%) and 18 (60%) respectively. 
 Regarding occupation majority of the samples are sedentary workers in both 
experimental group I 19 (63.33%) and in experimental group II   22(73.33%). 
 Regarding marital status most of them are married in experimental group I 
28(93.33%) and in the experimental group II 27(90%) respectively. 
 With regards to smoking history most of them had the habits of smoking in 
experimental group I 19(63.33%) and in experimental group II   12(40%) 
respectively. 
 
II. Clinical profile: 
 The majority of the sample had cancer larynx, 13(43.33%) in experimental 
group I and experimental group II 14(46.66%). 
  Regarding severity of the tumor in both experimental group I and II majority 
of the samples had tumor size ranging from (Tx – T4b), 20(66.66%) and 19 
(63.33%)  
  Regarding the dose of radiation administered per day for all the 
samples(100%)in both experimental group I and II were similar in receiving 
dose of 200 cGy per day.    
 The above data shows that experimental group I and group II were similar in 
the form of demographic variables such as age, sex, education status, 
occupation, marital status, history of smoking, location of the tumor, severity 
of tumor, dose of radiation therapy. 
 
III. Distribution of participants according to level of mucositis healing in 
experimental group – I showed that 10(33.33%) clients had mild ulceration and 
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20(66.66%) clients had moderate ulceration. After povidone- iodine mouth rinsing, on 
7
th
 day 22(73.33%) clients had mild ulceration and 8(26.66%) clients had moderate 
ulceration, on 14
th
 day 10(33.33%) clients had no ulcer, 18(60%) clients had mild 
ulceration and 2(6.66%) clients had moderate ulceration. For erythema 8(26.66%) 
clients had mild erythema, 22(73.33%) had moderate erythema. After using of 
povidone iodine mouth rinsing, on 7
th
 day 4(13.33%) clients had no erythema, 
26(76.66%) clients had mild erythema. This difference may be due to effect of 
povidone- iodine mouth rinsing. 
 
IV. Distribution of participants according to level of mucositis healing in 
experimental group- II showed that 15(30%) samples had mild ulceration  and 
15(30%) samples had moderate ulceration . After  using  of normal saline mouth 
rinsing, on 7
th
 day 21(70%) samples had mild ulceration  and 9(30%) samples had 
moderate ulceration, on 14
th
 day 5(16.66%) clients had no ulceration  and 19(63.33%) 
samples had mild ulceration  and 6(20%) samples had moderate ulceration. This is 
due to the effect of normal saline mouth rinsing. For erythema during pretest 
30(100%) samples had mild erythema, on 7
th
 day 3(10%) samples had no erythema 
and 27(90%) samples had mid erythema, on 14
th
 day 6(20%) samples had no 
erythema and 24 (80%) samples had mid erythema. 
 
V. The mean post test level of povidone iodine mouth rinsing (4.03) was lower than 
the pre test mean (11.06). 
 
VI. The mean post test level of povidone iodine mouth rinsing of the experimental 
group I(1.33) was lower than the pre test mean (6.6). 
 
VII.The mean post test level of normal saline mouth rinsing of the experimental 
group II(4.8) was lower than the pre test mean (10.23). 
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VIII. The mean post test level of normal saline mouth rinsing of the experimental 
group II(1.3) was lower than the pre test mean (6.7). 
 
IX. The post test mean ulceration score of experimental group I (4.03) after povidone 
iodine mouth rinse is significantly lower than the experimental group II(4.8). 
 
X. The mean post test erythema score of experimental group I(1.33) is significantly 
higher than the experimental group II(1.3). 
 
XI. There was a significant association between the pre test mucositis score of  
experimental group II and age the calculated value (86.8) at   (df- 3) was significant at 
0.05 level. 
 
CONCLUSION: 
The following conclusions were drawn from the study, 
 The level of oral mucositis status of subjects after use of povidone – iodine was 
lower than the level of oral mucositis status before use of  povidone – iodine 
mouth rinse. 
 The  level of  oral mucositis status of subjects after use of normal saline  was 
lower than the level of oral  mucositis status before use of normal saline  mouth 
rinse. 
 The povidone – iodine mouth rinse was found effective in improving the oral 
mucositis status of patient with oral mucositis when compared  with normal saline 
mouth rinse. 
 There was no significant association between the pre test oral  mucositis score of 
experimental group I and selected demographical variables such as  a age, sex, 
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education status, occupation, marital status, history of smoking, betel chewing, 
pan or kutka. 
 There was a significant association between the pre test mucositis score of 
experimental group II and  age the calculated value  X2 - 86.8 at (df -3) was 
significant at o.o5 level. 
 
IMPLICATION: 
 The findings of the study have practical application. The study could be 
discussed in four areas namely nursing practice, nursing administration, nursing 
education and research. 
 
a) Implication for nursing practice: 
 Early identification and prevention of oral mucositis among patient with head 
and neck cancer is essential. 
 As povidone- iodone and normal saline is less expensive and have no adverse 
effects, nurse can use readily. 
 Nurse must assess the oral  cavity of the patients receiving radiation therapy by 
using oral mucositis assessment scale to measure the mucositis status and treat 
accordingly. 
 The study findings will help the nursing personal to includes these nursing 
interventions in the management of oral mucositis. 
 There should be a routine practice of  using povidone –iodine and normal saline 
mouth rinse among  patient who develops oral mucositis. 
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b) Implication for nursing education : 
 This study has clearly proved that povidone – iodine mouth rinse was more 
effective in treating the oral mucositis. 
 These findings would help the nursing faculty to give importance to use 
povidone – iodine mouth rinse in the management of oral mucositis and 
motivate the nursing student to use of this in the management of oral 
mucositis among whom undergoing cancer treatment. 
 Different type of oral mucositis scale can be used in the nursing 
curriculum. 
 
c) Implication for nursing research: 
 There is a need for extensive and intensive research in this area. One of 
thise aims of nursing research is to expand and broaden the scope of 
nursing. Findings of this study will provide base line data about the oral 
mucositis healing and it can be used for further studies in these area. 
 
d) Implication for nursing administration: 
 Nursing administration can encourage the nursing personnel to conduct 
research on oral mucositis among patient with cancer and give care 
based on findings. 
 Periodic conference, seminars and symposium can be arranged for 
nursing personnel regarding care of oral mucositis among patient with 
cancer therapy. 
 Education should be given to clinical nurses and educators to updates 
knowledge regarding management of oral mucositis among patient with 
cancer. 
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 Nursing administrator’s should prepare procedure manuals and protocols 
regarding administration of mouth rinsing and use them in the wards and 
ensure the availability. 
 
LIMITATIONS:  
 Because of the small sample size and setting selection, The findings must be 
interpreted with caution. 
 Intervention given only for 14 days. 
 
 
RECOMMENDATIONS OF THE STUDY: 
 The study can be conducted by using large population to generalize the findings. 
 A longitudinal study can be conducted to assess the effectiveness of selected 
nursing interventions on reducing radiation induced oral mucositis. 
 Effectiveness of various other mouth rinse on oral mucositis can be done as 
comparative study in different settings. 
 The effectiveness of mouth rinse can be tested for other type of oral mucositis. 
 Qualitative study can be conducted to identify the in-depth oral  ulcer problems 
experienced by the patients who are receiving  radiation therapy. 
 Incidence of oral mucositis level can be assessed among cancer patient. 
 The same study can be repeated using true experimental design. 
 The study can assess the pain level of oral mucositis among patients   with head 
and neck cancer receiving radiation therapy. 
 An explorative study can be done to find out the side effects of radiation therapy 
among patients with head and neck cancer. 
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Nadu Dr.M.G.R. Medical university, Chennai in partial fulfillment of university 
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Date:                                                                                      (Rajathi. R)     
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APPENDIX - VII 
TOOL  TO ASSESS  THE ORAL MUCOSITIS LEVEL 
 
PART -I 
     a)Demographic Variables : 
1 Age a)18-28year 
b)29-38year 
c)39-48year 
d)49-58year 
2  Sex a)Male 
b)Female 
3  Education a)Illiterate 
b)Literate 
4 Occupation a)Sedentary worker 
b)Moderate worker 
5 Marital status a)Single 
b)Married 
c)Unmarried 
d)Window 
6 History of  tobacco, betel 
nut, pan or  kutka  chewing 
a)Yes/ No 
If yes duration 
b)No of cigarette/ beedi per day 
 
 
 
x 
b) Clinical Profile: 
1 Location of the tumor a)Lip 
b)Oral cavity 
c)Mouth 
d)Pharynx 
e)Larynx 
d)Pituitary gland 
2 Severity of tumor a)Tumor(Tx-T4b) 
b)Node involvement 
c)Metastasis 
3 Dose of radiation therapy for per day a)100cGy 
b)200cGy 
c)300cGy 
d)400cGy 
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APPENDIX – VIII 
PART - II 
ORAL MUCOSITIS ASSESSMENT SCALE 
 
 
 
  LOCATION 
 
 
ULCERATION 
 
 
PRE     
TEST 
 
POST   
TEST 
 
 
 
ERYTHEA 
 
 
PRE 
TEST 
 
 
 
POST TEST 
 
     DAY           DAY 
7
th
  14
th
  7
th 
 14
th
  
LIP 
  * Lower 
    
 
0-None 
1-<1cmsq 
2-<1.1- 3cm sq 
3-<3.1 cm sq 
  0-None 
1-Not severe 
2-Severe 
   
   
  
   *Upper 
0-None 
1-<1cmsq 
2-<1.1- 3cm sq 
3-<3.1 cm sq 
  0-None 
1-Not severe 
2-Severe 
   
BUCCAL MUCOSA 
   
   *Right 
 
0-None 
1-<1cmsq 
2-<1.1- 3cm sq 
3-<3.1 cm sq 
  0-None 
1-Not severe 
2-Severe 
   
 
     
    *Left 
0-None 
1-<1cmsq 
2-<1.1- 3cm sq 
3-<3.1 cm sq 
  0-None 
1-Not severe 
2-Severe 
   
TONGUE 
VENTROLATERAL 
  
   * Right 
 
    
0-None 
1-<1cmsq 
2-<1.1- 3cm sq 
3-<3.1 cm sq 
  0-None 
1-Not severe 
2-Severe 
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  LOCATION 
 
 
ULCERATION 
 
 
PRE     
TEST 
 
POST   
TEST 
 
 
 
ERYTHEA 
 
 
PRE 
TEST 
 
 
 
POST TEST 
 
     DAY           DAY 
7
th
  14
th
  7
th 
 14
th
  
 
      *Left 
    
 
0-None 
1-<1cmsq 
2-<1.1- 3cm sq 
3-<3.1 cm sq 
  0-None 
1-Not severe 
2-Severe 
   
   
  
*Floor of mouth 
0-None 
1-<1cmsq 
2-<1.1- 3cm sq 
3-<3.1 cm sq 
  0-None 
1-Not severe 
2-Severe 
   
PALATE 
   
    *Soft 
 
0-None 
1-<1cmsq 
2-<1.1- 3cm sq 
3-<3.1 cm sq 
  0-None 
1-Not severe 
2-Severe 
   
 
    *Hard 
 
0-None 
1-<1cmsq 
2-<1.1- 3cm sq 
3-<3.1 cm sq 
  0-None 
1-Not severe 
2-Severe 
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INTERPTETATION: 
Ulceration Erythema 
Categories Scoring Total Categories Scoring Total 
No ulcer 
Mild 
Moderate 
Severe 
0 
1 
2 
3 
0 
1 – 9 
10 – 18 
19 – 27 
No erythema 
Not severe 
Severe 
 
0 
1 
2 
0 
1 – 9 
10 – 18 
 
